Rule hypotheses
Useful enough to test. Not ready to trust blindly.
Every rule remains a candidate until it gains independent cross-case support, calibrated ranges, counterexamples, and acceptable false-positive costs.
113candidate rules
0corpus-validated rules
“Candidate” is a feature: it keeps one vivid case from hardening into false certainty.
rule.staged-channel-transition
Preserve the funding engine while staging the new channel through explicit adoption, quality, content-economics and distribution milestones; expand only when the evidence clears those gates.
Staging preserves downside capacity and creates information, while an existing customer relationship and broader distribution can lower the cost of learning about the new channel.
Use when
- An incumbent has a recurring customer relationship and a legacy engine capable of funding bounded experiments.
- A new distribution channel is strategically important but its adoption, technical readiness or input economics remain uncertain.
- Commitments can be sequenced so that evidence arrives before the largest irreversible investments.
Do not transfer when
- The legacy channel is deteriorating too quickly to fund the transition.
- Network effects, exclusive rights or distribution scarcity make delay more costly than bounded experimentation can offset.
- The new channel requires a single irreversible commitment before informative milestones can be observed.
Reverse or kill if
- New-channel engagement fails to deepen after content and distribution milestones are met.
- Input or rights commitments breach the approved cash-loss envelope without validated retention or pricing evidence.
- The legacy engine weakens enough that continued experimentation threatens liquidity or core service quality.
- A superior channel architecture makes the current transition path economically obsolete.
Limitations and promotion gaps
- Candidate status reflects evidence from one completed case; cross-case validation is still required.
- Netflix's transferable subscription relationship, content model and software distribution may not generalize to asset-heavy or regulated transitions.
- The case does not provide a deterministic estimate of the optimal investment pace or expected return range.
rule.stage-channel-transition-under-fixed-commitments
Gate each growth tranche on verified mature-cohort contribution while pruning legacy capacity and preserving downside liquidity.
Staging limits simultaneous cash claims from the old and new systems and preserves the option to redirect capital when new-channel economics disappoint.
Use when
- A legacy distribution system carries material debt, leases, or other fixed commitments.
- A replacement channel requires customer-acquisition or usage subsidies before its contribution economics are verified.
- Management can release investment in observable tranches.
Do not transfer when
- Delay would forfeit a demonstrably scarce opportunity whose expected cost exceeds the information value of staging.
- Cohort economics are already independently verified and downside liquidity remains ample after full commitment.
Reverse or kill if
- Halt acquisition scaling when mature cohorts remain contribution-negative beyond the approved payback window.
- Accelerate store exits or renegotiations when avoidable four-wall cash losses exceed credible customer-transfer benefits.
- Prioritize financing and fixed-cost reduction when stressed liquidity falls below the predeclared floor.
Limitations and promotion gaps
- The case does not reveal Blockbuster's cohort ledger or store-level contract terms.
- A single failure case cannot establish the optimal staging threshold across industries.
- Network effects or winner-take-most markets may increase the opportunity cost of staging.
rule.preserve-filing-vintages-before-comparison
Preserve both filing-vintage facts, link the later fact to the original, disclose the conflict, and abstain from a precise trend calculation until the basis is reconciled.
Separate vintage lineage prevents later information from overwriting the historical record and avoids attributing accounting-scope changes to business performance.
Use when
- The same issuer presents a materially different value for the same metric and period in a later filing.
- The available evidence does not fully reconcile scope, classification, or accounting-basis changes.
Do not transfer when
- The later filing supplies a complete reconciliation and the analysis labels the reconciled basis explicitly.
Reverse or kill if
- Withdraw the derived trend if a later source reveals an unreconciled scope or classification difference.
- Replace abstention only after the reconciliation itself has source-to-output lineage.
Limitations and promotion gaps
- Materiality depends on the decision and metric; not every filing-vintage difference changes a conclusion.
- The Blockbuster evidence retained here identifies the difference but does not explain its accounting cause.
rule.gated-operating-system-transplant
Use a staged transplant with explicit labor, governance, training and operating gates; release capital and volume only as comparable local evidence clears those gates.
A bounded site converts tacit operating knowledge into testable local routines, while precommitted gates keep market-access urgency from overriding quality, worker and capital evidence.
Use when
- A company has a demonstrated operating capability at home but limited evidence that it transfers across a new labor, supplier or regulatory system.
- A partner or existing asset can create a smaller and more reversible learning platform than a full independent build.
- The essential routines can be expressed as observable governance, training, quality, workflow and worker-participation requirements.
Do not transfer when
- The partner cannot grant adequate control over quality, safety, training or information.
- Legacy environmental, labor, layout or pension liabilities cannot be bounded.
- Delay destroys a scarce strategic position whose value is independently verified to exceed the learning option.
Reverse or kill if
- Executed terms deny the company sufficient authority to protect quality, safety or training integrity.
- Apparent productivity depends on unsafe pace, hidden rework, inventory displacement or suppressed worker representation.
- Capital, guarantees or contingent liabilities exceed the approved downside envelope.
- Comparable local quality and productivity fail to improve after the agreed adaptation window.
Limitations and promotion gaps
- Candidate status reflects one completed episode and requires cross-case validation.
- The episode does not estimate an optimal ownership percentage, capital budget or transfer duration.
- Retrospective issuer evidence and nonexperimental plant comparisons limit causal precision.
rule.separate-local-proof-from-enterprise-outcomes
Evaluate the local mechanism with plant-level quality, productivity, workforce and training evidence; present enterprise financial outcomes separately unless a deterministic causal bridge is validated.
Scope separation prevents a plausible local contribution from being inflated into unsupported attribution for consolidated value creation.
Use when
- A local operational intervention precedes favorable enterprise-level sales or profit outcomes.
- The enterprise outcome also reflects product mix, currency, acquisitions, geography, demand or later capital-allocation decisions.
- Plant-level operating evidence and consolidated financial evidence have different scopes.
Do not transfer when
- A validated causal design and deterministic bridge isolate the intervention's contribution to enterprise outcomes.
Reverse or kill if
- Local operating comparisons use inconsistent definitions or selected periods.
- Consolidated outcomes are presented as caused by the intervention without a validated bridge.
- Material rival explanations are excluded from the evidence packet.
Limitations and promotion gaps
- The rule improves evidence discipline but does not identify the intervention's true causal share.
- A lack of attribution evidence should produce uncertainty, not an assumption of zero contribution.
rule.integrated-safety-gate-before-schedule-commitment
Require an independent aircraft-level safety gate before binding schedule and production commitments; keep every material design change synchronized with hazard analyses, certification artifacts, combined-failure tests, warnings, procedures, maintenance, training, and regulator communication.
Integrated review exposes adverse interactions, stale assumptions, fragmented evidence, and reliance on idealized operator response before commercial commitments make redesign harder.
Use when
- A legacy product derivative materially changes propulsion, structure, controls, warnings, maintenance, training, or other interacting safety-relevant functions.
- Competitive or customer timing pressure creates incentives to freeze schedule, commonality, or training commitments before the complete architecture is validated.
- Certification relies partly on delegated findings, reused assumptions, or operator response to mitigate material failure conditions.
Do not transfer when
- The change is demonstrably isolated and cannot create or alter a material aircraft-level failure condition.
- A stricter independent process already supplies equivalent integrated evidence and decision authority.
Reverse or kill if
- Independent review cannot close a material aircraft-level hazard within the approved design envelope.
- Certification artifacts or training and maintenance materials remain stale after a material design change.
- Program economics depend on suppressing a safety-relevant difference, warning, procedure, training requirement, or regulator communication.
- Cumulative legacy constraints erase the derivative's claimed timing, commonality, or return advantage.
Limitations and promotion gaps
- Candidate status reflects one reconstructed failure case; cross-case validation is required before promotion.
- The rule does not prescribe a particular technical design or replace regulator, engineering, operational, or human-factors judgment.
- The case cannot quantify the probability reduction or optimal cost of the gate.
rule.separate-program-costs-from-portfolio-shocks
Preserve directly labeled program amounts, build a deterministic reconciled bridge for any broader attribution, and abstain from assigning aggregate financial changes to the program until identified confounders are controlled.
Separating reported program amounts from multi-causal portfolio outcomes prevents salient-event bias and double counting while retaining the financial consequences that are directly evidenced.
Use when
- A material program failure overlaps with macroeconomic, portfolio, production, accounting, or financing shocks.
- Filings disclose both program-specific charges or liabilities and aggregate financial changes.
- Decision makers want to attribute revenue, cash flow, leverage, or value destruction to the program.
Do not transfer when
- The program is the entire reporting entity and no other material shocks or accounting-basis changes are present.
- An audited causal bridge already isolates all material drivers and reconciles to the financial statements.
Reverse or kill if
- Source definitions or periods are incompatible and cannot be reconciled.
- A material program amount is an estimate whose uncertainty dominates the proposed conclusion.
- Identified external or portfolio shocks cannot be separated from the aggregate endpoint.
- A later filing materially revises the program amount or reporting basis.
Limitations and promotion gaps
- The rule prevents over-attribution but does not itself estimate economic loss, enterprise value, or counterfactual performance.
- Program-specific charges may overlap liabilities, payments, concessions, insurance, or future costs and must not be summed without a reconciliation.
- Candidate status reflects one completed case and requires cross-case testing.
rule.stage-platform-adjacency-under-unknown-unit-economics
Launch a bounded beta with explicit cohort, contribution, reliability, support and capital gates; expand access and scope only as evidence clears those gates.
A limited launch converts an adjacency thesis into customer and operating evidence while preserving the option to stop before broad fixed commitments.
Use when
- An incumbent has a demonstrated internal capability and an adjacent external customer problem, but standalone unit economics and retention are not yet observable.
- A limited product can expose real customer usage before the largest fixed-capacity and organizational commitments are made.
- The incumbent can fund a capped experiment without threatening core obligations or service reliability.
Do not transfer when
- The beta cannot be isolated from a large irreversible capacity or regulatory commitment.
- Core liquidity, operating reliability or managerial attention is already below the approved safety threshold.
- Customer harm or mission-critical reliability makes live experimentation inappropriate.
- Delay would forfeit a scarce right or network position whose value has independent, cited support.
Reverse or kill if
- Repeat usage fails to deepen after product and onboarding milestones are met.
- Normalized contribution remains outside the approved loss envelope without a verified path to improvement.
- Reliability incidents or core-business spillovers breach the safety gate.
- Fixed capacity or support commitments become economically irreversible before demand is validated.
- Core liquidity or cash generation falls below the approved funding cushion.
Limitations and promotion gaps
- Candidate status reflects one completed success case and no completed controlled counterexample.
- Later AWS segment results do not identify the causal contribution or optimal size of the original beta.
- The rule may not transfer to regulated, safety-critical or naturally indivisible infrastructure investments.
- No deterministic estimate of the optimal beta budget or expected return range is supported by this episode.
rule.gate-fixed-commitment-growth-on-duration-matched-cash-economics
Separate survival financing from the market transaction, stop or cap new fixed commitments, and permit expansion or capital-market relaunch only after unconditional liquidity, mature-cohort cash, duration and governance gates clear.
Short customer duration against long fixed commitments turns demand or financing weakness into cash stress; reversible commitment gates preserve the option to restructure before that stress exhausts liquidity.
Use when
- Customer commitments are materially shorter or more cancellable than the fixed leases, assets or debt required to serve them.
- Growth consumes cash and depends on recurring external financing rather than demonstrated self-funding economics.
- A material share of operating cohorts is immature or lacks verified full-cycle cash contribution data.
Do not transfer when
- Customer revenue is itself non-cancellable and duration-matched to the fixed commitment under a verified downside cash schedule.
- The new commitment is contractually reversible at a bounded cost already funded inside the approved loss envelope.
- Delay would forfeit a scarce right whose value and financing are independently supported by cited evidence.
- Safety, regulatory or contractual duties require continued service despite unattractive economics.
Reverse or kill if
- Unconditional liquidity falls below the approved operating and fixed-obligation reserve.
- Mature cohorts fail the precommitted cash contribution or payback gate under the downside case.
- Customer duration or termination exposure cannot support the non-cancellable fixed commitment without an explicit funded reserve.
- Financing remains contingent on a discretionary transaction whose price, proceeds or completion are not executable.
- Governance or related-party conflicts prevent independent enforcement of the approved cash and commitment gates.
Limitations and promotion gaps
- Candidate status reflects one completed failure case and no completed controlled counterexample.
- The episode does not quantify how much of the 2023 outcome was caused by the structure visible in 2019.
- Lease obligations, customer backlog and available financing have different legal, timing and measurement bases and must not be netted without reconciliation.
- The rule may not transfer to duration-matched, pre-funded, regulated or naturally indivisible infrastructure investments.
- No deterministic estimate supports a universal liquidity cushion, contribution threshold or payback range.
rule.apple.focus-stabilize-complementors-under-platform-distress
Narrow the product and project portfolio, secure bounded complementor commitments, and release cash and roadmap commitments only against predeclared operating and governance gates.
Focus concentrates scarce engineering and working capital while complementor commitments reduce platform abandonment risk; gates limit concentration, control and runway downside.
Use when
- A proprietary platform faces declining share, product sprawl, constrained liquidity and a transition in its core architecture.
- Essential applications or standards depend on complementors whose commitment is uncertain.
- Product, developer, channel and liquidity outcomes can be observed before the next irreversible commitment.
Do not transfer when
- Product concentration eliminates the only credible revenue path before a replacement is validated.
- Complementor terms surrender the architecture, customer relationship or economics required for differentiation.
- The liquidity runway is too short to test the gated program safely.
Reverse or kill if
- Initiate financing or strategic alternatives if the minimum liquidity runway is breached.
- Reopen portfolio scope if demand, quality or gross-margin gates fail twice.
- Reject or renegotiate complementor terms that transfer decision-critical platform control.
- Escalate immediately if no accountable executive owns a decision-critical gate.
Limitations and promotion gaps
- One successful turnaround cannot establish a cross-case base rate.
- The public record cannot show which exact gates Apple used internally.
- Focus may destroy option value in markets where customer needs are not yet observable.
rule.apple.separate-enabling-agreement-from-enterprise-outcome
Classify the agreement as enabling, necessary, sufficient or incidental only after tracing the intervening mechanisms and testing at least one operating and one external rival hypothesis.
An agreement can remove a binding constraint without executing the product, cost, channel and ecosystem actions that create later enterprise value.
Use when
- A financing, partnership, settlement or major-customer agreement occurs near an inflection point.
- Later enterprise performance follows multiple products, leaders, investments and secular market shifts.
- Aggregate disclosures do not identify the agreement's counterfactual causal contribution.
Do not transfer when
- A controlled or contractually deterministic record directly identifies the agreement's isolated economic effect.
- No material intervening decisions or external shocks exist between action and outcome.
Reverse or kill if
- Withdraw sole-cause language when a material intervening mechanism or external rival is discovered.
- Downgrade confidence when aggregate outcomes cannot be mapped to product- or period-specific evidence.
- Stop extending the causal chain when later evidence is contextual but not mechanism-bearing.
Limitations and promotion gaps
- Public evidence can establish sequence and plausible mechanisms without identifying causal shares.
- The rule needs validation against failures and cases with genuinely deterministic contract effects.
rule.stage-platform-transition-with-bridge-gates
Maintain a controlled customer-support bridge and compare successor platforms through time-boxed reference-device, commercial, carrier, developer, and contribution gates before full commitment.
Staging converts platform narratives into observable commitments while limiting transition signaling and preserving the option to reject a weak partner or product path.
Use when
- A legacy platform still contributes cash or customer value but is losing ecosystem competitiveness.
- A successor platform commitment is difficult to reverse and its partner economics, carrier support, or product delivery remain testable but unverified.
- A bounded proof can finish before the legacy demand bridge is likely to fail.
Do not transfer when
- The market is winner-take-most and even a short proof would irreversibly forfeit developer, carrier, or network-effect position.
- No representative reference-device or commercial proof is technically or contractually feasible.
- The legacy bridge is already economically nonviable and immediate shutdown dominates continued support.
Reverse or kill if
- End parallel platform work at the predeclared deadline even if evidence is incomplete.
- Stop a proof that cannot secure minimum carrier, developer, and contribution commitments.
- Protect liquidity if stressed transition runway falls below the approved minimum.
Limitations and promotion gaps
- One failure case cannot establish the optimal length or value of a staged proof.
- Nokia's public record does not show that Android access or a representative dual-platform proof was feasible within nine months.
- Staging can worsen outcomes when delay destroys ecosystem coordination faster than evidence arrives.
rule.separate-platform-choice-from-execution
Underwrite platform choice, transition design, product execution, channel execution, and external market shift as separate causal variables with distinct evidence and falsifiers.
A platform can be strategically plausible yet fail through timing or execution, while strong execution cannot guarantee that a structurally weak platform wins; separating the variables prevents monocausal hindsight.
Use when
- A business outcome follows a major technology or ecosystem choice.
- Product cadence, distribution, organization, legacy transition, and external market structure also changed over the measurement window.
Do not transfer when
- Controlled evidence isolates one factor as sufficient and rival hypotheses fail their predeclared tests.
Reverse or kill if
- Withdraw a causal conclusion when its supporting evidence is only management attribution or temporal sequence.
- Reopen the hypothesis when matched products, regions, or competitors contradict the assigned mechanism.
Limitations and promotion gaps
- Public filings rarely disclose product-level causal weights or rejected internal alternatives.
- Separating mechanisms improves discipline but may not identify their interaction or relative magnitude.
rule.acquire-under-independent-price-reserve-and-liquidity-gates
Pursue the control acquisition only at or below the independent price cap after reserve, return, funding, regulatory, and management-retention gates clear; otherwise retain the existing position or allocate elsewhere.
Patient ownership and operating autonomy can let a durable low-cost model reinvest for long-term customer and policy growth, while hard price, reserve, and liquidity gates prevent strategic fit from becoming permission to overpay or weaken claims-paying capacity.
Use when
- The buyer understands the target's business model and already has evidence of durable customer value, operating economics, and capable management.
- Control can preserve the managers and decentralized operating conditions that are material to the thesis.
- An independent valuation can set a maximum per-share price and required prospective return under adverse operating and reserve cases.
- Transaction funding can preserve regulatory capital, claims-paying ability, and a precommitted liquidity cushion.
Do not transfer when
- Reserves, claims development, or capital requirements cannot be independently verified under adverse scenarios.
- The proposed consideration exceeds the required-return price cap or a superior opportunity offers a higher downside-adjusted return.
- Funding would reduce unrestricted liquidity or regulatory capital below the approved cushion.
- Key management, succession, incentives, or decentralized decision rights cannot be preserved.
- Growth economics depend on unverifiable customer-acquisition, retention, claim, or advertising assumptions.
Reverse or kill if
- Proposed consideration exceeds the independently approved maximum price or required-return hurdle.
- Independent actuarial review identifies adverse reserve development outside the approved valuation or capital range.
- Funding reduces liquidity, claims-paying ability, or regulatory capital below the board-approved cushion.
- Management retention, succession, incentives, or operating autonomy materially deteriorate.
- Quote conversion, policy retention, acquisition cost, or reserve-normalized underwriting fails the precommitted cohort gate.
- A superior cited use of capital provides a higher downside-adjusted per-share intrinsic-value outcome.
Limitations and promotion gaps
- Candidate status reflects one completed case and no completed controlled counterexample.
- The episode does not disclose the ex ante acquisition model or calculate realized acquisition IRR.
- Later GEICO results cannot isolate the contribution of full ownership from management, direct distribution, advertising, brand, technology, pricing, underwriting, and secular adoption.
- The rule may not transfer to unverifiable, integration-dependent, nonfinancial, or rapidly obsolescing businesses without material adaptation.
rule.danaher.system-is-not-price
Underwrite target selection, fully financed price, downside return, financing resilience and customer-safe integration as separate gates before authorizing a bid or close.
A repeatable operating system may improve execution, but it cannot mathematically offset any purchase price, refinancing exposure or target-selection error.
Use when
- An acquirer has a documented repeatable operating and integration system.
- A target appears strategically adjacent and the transaction is material to capital or management capacity.
Do not transfer when
- The transaction is demonstrably immaterial under an approved threshold and cannot impair liquidity or operating continuity.
Reverse or kill if
- Walk away if price exceeds the approved ceiling.
- Stop if financing headroom or customer-safe integration cannot be verified.
Limitations and promotion gaps
- One case cannot estimate a general acquisition-system success rate.
- Public evidence does not reveal Danaher's internal return model or integration cohorts.
rule.danaher.decompose-perimeter
Build an explicit perimeter bridge and keep reported, existing-business, acquisition, divestiture, currency and analyst-normalized measures distinct.
Without a perimeter bridge, headline growth can falsely attribute purchased or translated revenue to operating execution.
Use when
- Reported growth spans acquisitions, divestitures, currency changes or segment redefinitions.
Do not transfer when
- Verified evidence establishes a genuinely unchanged perimeter and immaterial currency effects.
Reverse or kill if
- Retract the comparison if segment definitions or acquisition dates cannot be aligned.
- Reclassify the conclusion when later filings materially revise the perimeter.
Limitations and promotion gaps
- Issuer-defined existing-business or core growth may remain non-GAAP and require definition review.
- A reconciled bridge improves measurement but does not itself establish causality.
rule.danaher.gate-separation
Treat the separation as a distinct transaction with tax, stranded-cost, capital-structure, governance, systems, customer and employee continuity gates.
Focus benefits can be consumed by tax leakage, duplicated cost, weak standalone capitalization or operational disruption.
Use when
- Management proposes a portfolio separation to improve strategic focus.
Do not transfer when
- The assets are already operationally and legally standalone with verified immaterial transition costs.
Reverse or kill if
- Defer if tax treatment or standalone financing is unacceptable.
- Stop if customer, employee or systems continuity cannot be protected.
Limitations and promotion gaps
- Completion of Fortive does not independently quantify value created by focus.
- Separation economics are company- and jurisdiction-specific.
rule.gate-transformational-acquisition-on-cash-and-complexity
Prefer the narrower reversible structure and prohibit full-scope commitment until final price definitions, contract-cohort cash returns, stressed funding, liabilities, controls and integration costs clear precommitted deterministic gates.
A full commitment converts uncertain market, contract and execution assumptions into balance-sheet exposure before learning can improve the decision; staging preserves the option to stop, reprice or carve out weak assets.
Use when
- A proposed acquisition is large relative to the buyer's directly available industrial-parent liquidity or adds multiple reporting, legal, governance and integration boundaries.
- Strategic support relies materially on backlog, installed base, synergies or EPS accretion while contract cash quality and downside demand remain unverified.
- A narrower, staged or jointly owned structure can preserve some strategic option value.
Do not transfer when
- Delay would destroy a demonstrably scarce opportunity and a source-backed downside model shows that the opportunity cost exceeds the information value of staging.
- Contract cash quality, liabilities, controls, integration capacity and directly available funding are independently verified with ample downside headroom.
Reverse or kill if
- Withdraw when a complete downside cash model fails the precommitted return hurdle at the final price.
- Carve out or stop when contract, compliance, pension, environmental, product or litigation exposure cannot be bounded.
- Stop relying on backlog or synergy when cancellations, utilization, price, working capital or cost-to-achieve breach the approved case.
- Narrow the structure when parent liquidity or integration capacity falls below its board-approved floor.
Limitations and promotion gaps
- This case does not reveal GE's internal diligence, board minutes, signed return model or rejected alternatives.
- The counterfactual narrower structure was negotiable in some form but is not proven executable on the frozen recommendation's economics.
- One failure case cannot establish universal thresholds or prove that every large acquisition should be staged.
rule.preserve-transaction-value-vintages
Store each definition and reporting vintage separately and abstain from a transaction-cost or value bridge until every scope and currency adjustment has source-to-output lineage.
Silent reconciliation can turn different economic and accounting objects into a false precision that contaminates returns, goodwill attribution and post-deal scorekeeping.
Use when
- Issuers or filings use different equity-value, enterprise-value, total-value, purchase-price, net-cash or fair-value labels for the same transaction.
- Currency dates, noncontrolling interests, joint ventures, remedies, working capital or acquired-cash treatment may differ.
Do not transfer when
- Executed documents and filed schedules provide a complete, arithmetically reproducible reconciliation across all definitions and currencies.
Reverse or kill if
- Withdraw a derived return or cost bridge when a later source reveals a scope, currency or accounting-basis mismatch.
- Replace abstention only after the reconciliation itself is reproducible and citation-complete.
Limitations and promotion gaps
- Different labels can all be correct for their stated purpose; the rule requires separation, not choosing one as inherently superior.
- The captured GE and Alstom sources do not supply a complete bridge across every announced and accounting amount.
rule.accounting-verification-and-liquidity-gate
Suspend new capital and reduce or exit to a de minimis verification hold until independent accounting, cash, counterparty, collateral, governance, and liquidity gates clear.
When reported value and liquidity depend on counterparties or structures supported by the issuer itself, a fall in confidence or issuer equity can simultaneously weaken hedges, increase collateral needs, reduce funding access, and expose prior reporting errors.
Use when
- A complex trading or financial issuer reports large gross fair-value assets and liabilities that cannot be reconstructed by contract, counterparty, collateral, maturity, and enforceable netting set.
- Reported earnings or historical operating cash inflow coexist with current cash outflow, material collateral or margin movements, and incomplete unrestricted-cash reconciliation.
- Executive-controlled counterparties, issuer-share collateral, unconsolidated entities, or auditor-independence concerns impair objective verification.
- Ratings, share price, collateral calls, or counterparty confidence can feed back into liquidity.
Do not transfer when
- Independent contract and bank confirmations reconcile every material balance and cash movement.
- Legal opinions establish enforceable netting and collateral rights, and severe combined stress leaves ample unrestricted liquidity.
- Related parties are independently controlled, economically capitalized, fairly priced, and excluded from executive self-dealing.
- The apparent cash-flow weakness is demonstrably seasonal or mechanical and fully reversible without counterparty, rating, or refinancing dependence.
Reverse or kill if
- Cross-case testing shows that the conditions frequently flag sound issuers whose contract-level evidence and liquidity remain robust.
- Independent evidence clears the accounting, economic-risk-transfer, governance, and combined-liquidity gates.
- The rule cannot distinguish ordinary collateral seasonality from a confidence-sensitive liquidity spiral with acceptable false-positive rates.
Limitations and promotion gaps
- This is a single-case candidate rule, not a corpus-validated universal law.
- It is a verification and exposure-sizing rule, not a fraud classifier.
- Mark-to-market accounting, an SPE, related-party disclosure, negative cash flow, or non-audit fees alone are insufficient triggers.
rule.worldcom.verification-before-exposure
Suspend new equity exposure and require independent accounting, control, governance and financing verification; exit or reduce to a predeclared de minimis position when downside protection is not independently demonstrable.
Reporting opacity and refinancing dependence can reinforce each other, turning a control or confidence break into rapid loss of funding access and common-equity value.
Use when
- A public company combines weakening results, material estimates or acquisition accounting, unusual related-party governance exposure and executive turnover.
- The capital structure also depends on near-term refinancing or ratings-sensitive liquidity.
Do not transfer when
- Verified evidence establishes immaterial exposure, signed financing, effective controls and ample downside capitalization under a board-approved threshold.
Reverse or kill if
- Re-open underwriting only after signed financing and independent reporting and control tests pass.
- Kill the rule if cross-case evidence shows the signal cluster adds no useful loss-avoidance information after base rates and industry conditions are controlled.
Limitations and promotion gaps
- One failure case cannot estimate the cluster's predictive precision or optimal de minimis threshold.
- Each signal can have benign explanations, so the rule requires a cluster and verification rather than an allegation.
rule.worldcom.liquidity-is-conditional
Reconstruct accessible liquidity from signed commitments after collateral, covenants, borrowing bases, conditions, maturities and stressed operating needs; keep headline capacity and drawable availability separate.
A nominal facility can disappear or become uneconomic precisely when ratings, collateral or covenant conditions deteriorate.
Use when
- Management reports available liquidity that includes undrawn revolvers, receivables programs or facilities nearing maturity or waiver expiration.
Do not transfer when
- Cash is unrestricted and lender-confirmed commitments are unconditional, long-dated and demonstrably drawable under the approved downside case.
Reverse or kill if
- Retract any liquidity conclusion when a facility or waiver expires, is terminated or becomes non-drawable.
- Reclassify capacity only after executed documents and lender confirmation resolve the restriction.
Limitations and promotion gaps
- Public filings may not expose intraday cash, borrowing-base detail or lender discretion.
- Conservative treatment can create false positives when refinancing markets remain open and facilities renew normally.
rule.worldcom.separate-equity-from-operations
Analyze reporting integrity, legal capitalization, common-equity recovery, creditor claims and operating-asset value as separate layers before describing the entire business as worthless.
Debt priority, restatement, governance failure and reorganization can destroy existing equity while networks, contracts, customers and operating capabilities retain going-concern value.
Use when
- A company experiences severe reporting failure, insolvency, restructuring or common-equity impairment while operating assets and customer services continue.
Do not transfer when
- Verified evidence establishes that operations ceased and recoverable operating-asset value is immaterial after wind-down costs.
Reverse or kill if
- Reclassify the business as a wind-down when customer, service, funding and reorganization evidence fails.
- Do not infer equity recovery from operating continuity without a complete claims waterfall.
Limitations and promotion gaps
- Operating continuity does not prove positive common-equity value or quantify recoveries.
- One telecommunications reorganization does not establish the rule's precision across asset-light or rapidly obsolescing businesses.
rule.verify-survival-liquidity-by-asset-and-entity
Treat reported liquidity as an issuer claim until a security-level and legal-entity ledger proves same-day usability after encumbrance, clearing, transfer, haircut, settlement, and stressed-outflow deductions.
Liquidity that is owned but trapped, pledged, operationally indispensable, slow to settle, or nonmonetizable under stress cannot meet current obligations when counterparties withdraw together.
Use when
- The business depends on daily or very short-term funding, collateral acceptance, clearing access, or counterparty confidence.
- Management reports a liquidity pool without an independently reconciled asset, encumbrance, legal-entity, operational-use, haircut, and settlement schedule.
- A name-specific stress could make ordinary market liquidity unavailable.
Do not transfer when
- The institution has no material maturity transformation, collateral calls, clearing dependency, or legal-entity transfer constraint.
- A regulator or independent control function has already verified the same asset-level schedule under a stress at least as severe as the decision case.
Reverse or kill if
- Withdraw a survival-liquidity conclusion when an asset cannot be monetized at the assumed time, haircut, entity, or operational cost.
- Escalate capital, asset sales, or resolution planning if two funding channels deteriorate together or a critical clearer restricts access.
- Restore confidence in the measure only after the ledger and stress assumptions are independently reverified.
Limitations and promotion gaps
- The Lehman public record does not reveal the complete cutoff-date asset-level ledger or establish the optimal survival horizon.
- One failure case cannot determine universal haircuts, thresholds, or transfer assumptions across legal and regulatory regimes.
- Public nonverification is not proof that an issuer's reported pool is false.
rule.count-only-permanent-economic-deleveraging
Count deleveraging only after settlement, exclude temporary reporting-date transactions, test at least a thirty-day look-forward for reversal, and show gross and issuer-defined net measures with their definitions.
Temporary or definitional balance-sheet compression can improve a reported ratio without durably reducing exposure, funding demand, loss capacity, or counterparty risk.
Use when
- Management claims balance-sheet or leverage reduction in a confidence-sensitive or capital-constrained institution.
- Transactions can temporarily reduce reporting-date assets while exposure, financing need, or repurchase obligation returns soon after.
- Gross leverage and issuer-defined net leverage differ materially.
Do not transfer when
- The transaction permanently transfers both economics and funding exposure and is independently confirmed at settlement.
Reverse or kill if
- Reverse credited deleveraging when exposure returns, a repurchase obligation becomes likely, or replacement positions restore the same risk.
- Reopen the conclusion when a later investigative or filing vintage changes the reported scope or ratio definition.
- Escalate to capital and liquidity controls if sale losses consume more loss-absorbing equity than the permanent risk reduction supports.
Limitations and promotion gaps
- Thirty days is a governance convention from the case design, not an empirically established universal horizon.
- Permanent gross-asset reduction can still fail to reduce risk if retained positions become less liquid or hedges weaken.
- The examiner's later Repo 105 record demonstrates a presentation risk but does not prove that every reported Lehman reduction was temporary.
rule.separate-disclosure-failure-from-failure-causation
Analyze disclosure effect, economic mechanism, legal status, and ultimate failure causation as separate propositions, each with its own evidence, rivals, and falsifier.
A material transparency defect can affect confidence and decisions without being necessary or sufficient for failure, while an investigative threshold does not establish adjudicated liability.
Use when
- Later evidence reveals a material nondisclosure, accounting presentation, internal-control defect, or investigative finding.
- The business outcome also involves funding, asset values, management actions, counterparties, competitors, regulation, or macro shocks.
- The legal or investigative source uses a threshold such as colorable rather than a final adjudication.
Do not transfer when
- Controlled or adjudicated evidence directly establishes the specific causal or liability proposition being stated.
Reverse or kill if
- Withdraw a monocausal statement when credible rival mechanisms remain supported.
- Relabel a legal conclusion whenever a later court record changes the procedural or adjudicative status.
- Reopen the disclosure analysis if evidence shows counterparties did not know of or respond to the presentation at the relevant time.
Limitations and promotion gaps
- Public records rarely identify counterparty-by-counterparty reliance or isolate causal weights.
- Separating propositions disciplines language but does not by itself identify how mechanisms interacted.
- The examiner's findings and Federal Reserve testimony were published after the decision cutoff and cannot grade what a cutoff-date analyst knew.
rule.raise-loss-absorbing-capital-before-confidence-closes
Raise genuinely loss-absorbing common equity early enough to settle before forced asset sales, and size it against independently priced downside marks rather than the headline offering amount.
Common equity can absorb realized sale losses and collateral stress, but a late or structurally weaker security may not restore confidence once marks, withdrawals, and funding constraints reinforce one another.
Use when
- A leveraged intermediary has material hard-to-monetize exposure and funding that depends on confidence.
- Stressed sale losses, collateral haircuts, or liquidity deductions are not independently bounded.
- Capital-market access exists but could narrow sharply after another loss or counterparty shock.
Do not transfer when
- Verified downside capital remains comfortably above all regulatory, contractual, and going-concern floors after stressed losses.
- An alternative permanent risk transfer eliminates the exposure without recourse, retained funding demand, or contingent loss.
Reverse or kill if
- Increase the raise or accelerate risk reduction when independently priced downside losses exceed the planned buffer.
- Stop relying on a transaction if commitments, conditions, or settlement timing become uncertain.
- Withdraw a capital-adequacy conclusion if market access closes before proceeds settle or if asset marks and collateral calls outrun the buffer.
Limitations and promotion gaps
- The record does not establish how much additional common equity was available, at what dilution, or whether it would have prevented failure.
- Raising capital can itself signal weakness and accelerate adverse selection or counterparty withdrawal.
- Preferred and mandatory-convertible instruments may absorb losses differently; their treatment depends on exact terms and the relevant regulatory or going-concern question.
rule.svb.deposit-correlation
Segment runoff by controller, channel and network; stress correlated cohorts without assuming every uninsured dollar exits immediately.
Insurance status affects incentive, while common liquidity shocks and communication channels affect correlation and speed.
Use when
- A material share of deposits is uninsured
- Funding is concentrated in economically connected commercial cohorts
Do not transfer when
- Verified beneficial-owner and behavioral evidence demonstrates low correlation under severe stress
Reverse or kill if
- Cross-case evidence shows insurance status and network segmentation add no predictive or decision value
Limitations and promotion gaps
- One failure cannot calibrate a universal runoff rate.
rule.svb.operational-liquidity
Calculate time-to-cash after haircuts, encumbrance, documentation, settlement and operational readiness; test the channels.
Nominal capacity can fail to become usable cash at the speed of a run.
Use when
- A liquidity argument relies on facilities
- collateral or securities monetization
Do not transfer when
- The funding is unconditional immediately available cash
Reverse or kill if
- Independent tests prove all counted capacity remains immediately drawable across severe scenarios
Limitations and promotion gaps
- Public filings rarely expose operational detail; human approval is needed for funding assumptions.
rule.svb.layered-causality
Model structural vulnerability, trigger, amplification and response as separate causal layers and preserve rival hypotheses.
A visible last event may accelerate failure without creating the balance-sheet and funding fragility that made failure possible.
Use when
- A failure follows a salient financing or disclosure event
- Pre-existing vulnerability evidence exists
Do not transfer when
- Primary evidence establishes that the event independently created the full vulnerability
Reverse or kill if
- Later primary evidence establishes a single sufficient cause and refutes material pre-existing mechanisms
Limitations and promotion gaps
- The rule structures analysis but does not estimate causal weights.
rule.walmart.validate-density-locally
Underwrite and release capital at the stable-scope cluster-and-route level, not from consolidated sales alone.
Density creates value only where local demand fills routes and facilities while service, inventory, and fully loaded costs improve; aggregate growth can mask weak clusters.
Use when
- A scale strategy depends on geographic density and a hub-and-spoke distribution network.
- Companywide growth has material co-causes and project-level route or cluster economics are observable.
- Capacity can be divided into meaningful capital or geographic tranches.
Do not transfer when
- Delay destroys a scarce site, service, or network option whose quantified expected cost exceeds the value of added evidence.
- No representative cluster can be isolated within the decision window.
Reverse or kill if
- Pause after two consecutive stable-scope service or return misses without a verified transient cause.
- Re-underwrite if route fill, inventory quality, or stressed liquidity falls outside the declared band.
Limitations and promotion gaps
- This case supplies aggregate and architectural endpoints, not a matched cluster causal estimate.
- The optimal tranche size depends on site scarcity, construction lead time, and network interdependence.
rule.walmart.control-interfaces-not-every-asset
Preserve auditable control of the decision-critical interfaces while choosing asset ownership and fulfillment mode by stable-scope service, continuity, labor, data-rights, and total-landed-cost evidence.
The value can reside in coordinated information and operating rules rather than universal ownership; format-specific external capacity can add flexibility without surrendering the system.
Use when
- The operating advantage combines information, allocation, supplier, warehouse, and transport interfaces.
- Formats, categories, and geographies have materially different direct, cross-dock, owned, and third-party flow economics.
Do not transfer when
- Contracting cannot protect decision rights, data, worker safeguards, continuity, or peak capacity.
- Asset specificity makes owned capacity demonstrably cheaper and safer through a full cycle.
Reverse or kill if
- Bring the interface in-house or change providers after repeated data-rights, continuity, labor, safety, or service failures.
- Divest or stop adding owned assets when matched external capacity wins through a full seasonal cycle without loss of control.
Limitations and promotion gaps
- Public filings do not provide matched owned-versus-outsourced route returns.
- Later eCommerce adaptation supports interface continuity but does not prove the legacy network caused digital success.
rule.walmart.keep-scale-scopes-separate
Preserve each endpoint as reported, declare every scope break, and abstain from causal percentages or valuation bridges until a deterministic reconciliation exists.
Apparent continuity can be an artifact of changing perimeter, while real operating continuity may sit below the reporting labels; explicit scope prevents both false attribution and false discontinuity.
Use when
- A long-horizon scale narrative crosses acquisitions, divestitures, formats, segments, geographies, ownership modes, or channels.
- Reported facility counts, purchase shares, sales, and digital metrics use changing definitions or precision.
Do not transfer when
- An authoritative stable-scope series and deterministic reconciliation bind every endpoint and adjustment.
Reverse or kill if
- Retract or relabel a bridge when a later filing reveals an unrecorded scope break.
- Recompute only through deterministic code and obtain human accounting approval for material adjustments.
Limitations and promotion gaps
- Scope discipline improves validity but does not itself identify causal effects.
- Some historical definitions may remain irreconcilable, requiring an explicit unknown rather than interpolation.
rule.preserve-member-surplus-before-fee-harvest
Preserve and measure member surplus before raising fees or merchandise margin; test price changes in stable cohorts and separate fee revenue from merchandise economics and operating profit.
A recurring fee can monetize trust only while the underlying operating system continues producing surplus; harvesting too early can weaken renewal, traffic, volume purchasing, vendor terms, and cost advantage together.
Use when
- Customers voluntarily pay a recurring access fee because the operating system credibly returns larger price, quality, convenience, or service value.
- Scale, assortment discipline, vendor terms, employees, distribution, and renewal are jointly measurable.
Do not transfer when
- The current fee materially underfunds the service or creates adverse selection and controlled evidence shows a price increase preserves lifetime value.
- The core format faces technological obsolescence or negative unit economics that member-price generosity cannot repair.
Reverse or kill if
- Renewal, visits, or spending fall outside controlled downside bands after a fee or margin action.
- Matched price advantage, quality, availability, or member trust materially weakens.
- Channel change makes the existing member proposition structurally obsolete despite reinvestment.
Limitations and promotion gaps
- Costco does not prove the rule for every subscription, marketplace, cooperative, club, or loyalty program.
- Renewal can remain high temporarily despite underinvestment, switching friction, or a deteriorating proposition.
- The Blockbuster pairing is an architectural counterexample about channel obsolescence, not a matched membership-club experiment.
rule.gate-physical-scale-on-stable-scope-unit-economics
Stage land, construction, inventory, staffing, and follow-on openings against cohort demand, complete site cash flows, working capital, employee capacity, cannibalization, and downside liquidity.
Aggregate growth can hide weak marginal cohorts; staged releases preserve option value and expose whether new sites reproduce the system rather than merely enlarging the reported perimeter.
Use when
- Growth requires repeated physical sites, inventory, staffing, vendor commitments, and preopening cost.
- Capital releases can be staged and new cohorts can be separated from mature operations.
Do not transfer when
- Scarce sites, network density, or contractual commitments make delay more costly than downside protection and the board has complete evidence.
Reverse or kill if
- New cohorts miss stressed cash and member-value hurdles after a defined remediation period.
- Liquidity, vendor terms, inventory quality, employee capacity, or service falls below the board floor.
Limitations and promotion gaps
- Public Costco filings do not reveal actual site-level return distributions or board gates.
- A favorable aggregate outcome does not prove every site or the hypothetical staged process was optimal.
- WeWork is a boundary case about scale without sufficiently proven unit economics, not a matched retail-club comparison.
rule.preserve-membership-and-period-definitions-before-trends
Store every observation with its exact definition, period, geography, consolidation perimeter, methodology, and public date; branch or abstain when no valid bridge exists.
Apparent growth or deterioration can be created by counting rules, extra weeks, consolidation changes, acquisitions, and scope rather than economics.
Use when
- A longitudinal analysis crosses memberships, members, households, primary cards, affiliates, additional cards, total cardholders, renewal windows, fiscal weeks, joint ventures, acquisitions, or channel definitions.
Do not transfer when
- A filed reconciliation establishes identical definitions and a deterministic bridge.
Reverse or kill if
- A metric cannot be reconciled to its filed definition and source span.
- A derived trend depends materially on an unbridged scope or methodology change.
Limitations and promotion gaps
- Preserving definitions prevents false precision but does not by itself explain causal performance.
rule.quality-aware-auction-rollout
Roll out the auction in bounded cohorts; combine economic bids with a verified quality signal and expand only after user, customer, abuse, pricing and normalized-contribution gates clear.
Outcome-linked pricing improves measurability, while quality weighting makes low-response high bids less able to dominate; staged traffic and holdouts reveal adverse selection, gaming and trust effects before broad commitment.
Use when
- A marketplace can move from impression pricing to outcome-linked pricing, but the outcome signal can be gamed or can reward low-quality supply.
- User trust depends on relevance and clear separation between commercial and non-commercial results.
- A capped treatment, stable holdout and reversible legacy product can expose real behavior before full migration.
Do not transfer when
- The measured outcome is not meaningfully connected to customer value.
- The quality signal can be manipulated more cheaply than the harm it creates.
- Regulation or safety requirements prohibit live experimentation.
- The legacy fallback cannot be retained and the migration is economically irreversible.
Reverse or kill if
- User quality, trust or latency breaches the control threshold.
- Mature customer cohorts fail to retain or achieve verified outcome value.
- Invalid events, refunds or support burden exceed the approved envelope.
- Quality weighting is manipulable or produces systematic low-quality winners.
- Normalized contribution remains negative without an approved and evidenced path to improvement.
Limitations and promotion gaps
- Candidate status reflects one historical episode and no completed controlled counterexample.
- Public evidence does not reveal Google's internal launch thresholds or validate an optimal quality-weight formula.
- The rule may not transfer to safety-critical or regulated allocations where experimental harm is unacceptable.
- No expected monetary range is supported.
rule.distribution-economics-and-governance
Reconcile partner-level contribution and concentration, cap dependency, preserve user choice and product neutrality, and require legal and governance review before exclusive or default-expanding commitments.
Distribution can compound demand but creates recurring acquisition cost and control over access; economic and governance gates prevent apparent top-line scale from hiding weak contribution or exclusionary dependence.
Use when
- A platform depends on defaults, affiliates, channel partners or paid access points for a material share of demand.
- Partner payments can accelerate scale while obscuring contribution and increasing bargaining or foreclosure risk.
- The platform also controls ranking, access or monetization rules affecting downstream participants.
Do not transfer when
- Distribution is immaterial and independently verifiable as non-exclusive and user-selected.
- Regulation dictates the access arrangement and leaves no discretionary ranking or exclusivity decision.
- The contract is a short, capped experiment with no renewal, default or foreclosure effect.
Reverse or kill if
- Partner contribution stays negative after normalized serving and support cost.
- Query or revenue dependency breaches the approved concentration limit.
- Default or exclusive terms materially impair user choice or rival access.
- The arrangement cannot pass independent competition and product-neutrality review.
- Contract economics or traffic cannot be reconciled to source records.
Limitations and promotion gaps
- Candidate status reflects one case and should not be treated as corpus-validated competition policy.
- The public episode lacks the actual Yahoo, EarthLink and later default contracts.
- Economic concentration thresholds must be specified for each market and cannot be inferred from this case.
- Legal findings vary by jurisdiction, market definition, conduct and procedural posture.
rule.stage-incumbent-platform-migration-under-unknown-economics
Approve a staged cross-platform and recurring-revenue migration with frozen definitions and precommitted paid-retention, combined-gross-profit, direct-contribution, investment, reliability, and execution gates; expand only after each wave clears them.
Staging converts strategic intent into cohort and workload evidence while preserving the option to protect legacy economics, pause weak products, and constrain fixed infrastructure and organizational commitments.
Use when
- An incumbent has valuable legacy cash flows and demonstrated cloud or platform capability before the proposed migration.
- Cross-platform distribution or subscription conversion can be released in measurable product and workload waves.
- Reported growth is bundled or standalone retention, contribution, cannibalization, and investment returns remain unknown.
- The incumbent has sufficient liquidity to fund a bounded learning program without compromising core obligations.
Do not transfer when
- Customer safety, regulation, or mission-critical continuity makes live experimentation inappropriate.
- The required capacity or ecosystem commitment is indivisible and economically irreversible before evidence can be observed.
- Delay would forfeit a scarce right or network position supported by independent, cited evidence.
- Core liquidity, reliability, or managerial capacity is already below its approved safety threshold.
Reverse or kill if
- Paid retention fails the frozen threshold after committed product and onboarding milestones.
- Combined comparable gross profit deteriorates beyond the approved duration or direct contribution lacks a verified improvement path.
- Infrastructure and operating investment breaches the approved envelope without revised utilization evidence.
- Reliability, customer harm, or cross-platform execution breaches the precommitted limit.
- Segment or metric redefinitions prevent management from enforcing the gates and no audited bridge is produced.
Limitations and promotion gaps
- Candidate status reflects one completed turnaround episode rather than a cross-case causal estimate.
- The public record does not establish that Microsoft used these exact internal gates.
- Later results include acquisitions, pandemic demand, market growth, changing definitions, and subsequent execution.
- The rule does not specify an optimal migration budget, pace, expected return, or target price.
rule.stage-deep-technology-platform-under-unknown-economics
Approve a staged developer-platform program with frozen cohort and cost definitions; expand only after active-developer retention, production-workload retention, workload contribution, investment, portability, reliability, and supply gates clear.
Staging converts platform intent into cohort and workload evidence while preserving the option to pause weak layers, cap fixed commitments, and distinguish ecosystem effects from hardware performance, supply, and external demand.
Use when
- A company has differentiated technical capability that can be exposed through a developer platform and expanded through discrete compiler, library, tool, and system releases.
- Prior art and credible competing architectures exist, so technical invention alone is not the thesis.
- Developer adoption, retained workloads, contribution economics, allocated investment, portability, and switching cost remain incomplete or company-defined.
- The company has enough liquidity and operating capacity to fund bounded learning without compromising core obligations.
Do not transfer when
- Safety, regulation, or mission-critical continuity makes live workload experiments inappropriate.
- The required silicon, foundry, tooling, or ecosystem commitment is economically indivisible before evidence can be observed.
- Delay would forfeit a scarce technical standard or distribution position supported by independent evidence.
- Liquidity, supply resilience, reliability, security, or managerial capacity is below an approved safety threshold.
Reverse or kill if
- Retained active developers or production workloads fail the frozen threshold after committed product and onboarding milestones.
- Workload contribution remains below the approved learning-loss envelope without a verified improvement path.
- Platform investment breaches the approved envelope and management cannot produce a reconciled allocation or credible payback path.
- Portability, reliability, security, or customer-harm evidence breaches a precommitted limit.
- Hardware performance or supply constraints dominate outcomes and software layers do not add independently verified retention or contribution.
- Metric redefinitions prevent enforcement of the gates and no audited bridge is produced.
Limitations and promotion gaps
- Candidate status reflects one completed platform episode rather than a cross-case causal estimate.
- The public record does not establish that NVIDIA used these exact internal gates.
- Later results include architecture and semiconductor advances, supply, acquisitions, demand shocks, competition, regulation, and subsequent execution.
- The rule does not specify an optimal investment budget, causal return, market value, or target price.
rule.gate-irreversible-capacity-protect-technology-learning
Separate continuous technology and yield investment from volume capacity, and release capacity modules only against stable-scope utilization, diversified binding demand and stressed liquidity thresholds.
Technology delay can forfeit customer relevance, while premature volume capacity spreads fixed costs over too little output; modular gates preserve learning and limit irreversible downside.
Use when
- A business has large fixed-cost capacity with long lead times and cyclically volatile utilization.
- Technology learning must continue before demand is fully observable.
- Capacity can be divided into project phases or equipment modules.
Do not transfer when
- Project phasing destroys the entire technology option or incurs cancellation costs greater than the downside avoided.
- Binding diversified demand and prepayments already cover the module's ramp economics.
Reverse or kill if
- Kill a capacity module when yield economics miss the approved ramp and binding demand falls below the contractual gate.
- Accelerate when delay would forfeit verified design wins and diversified prepayments cover downside.
Limitations and promotion gaps
- This single case does not establish a cross-industry base rate.
- Public filings do not reveal project-level cancellation costs or exact board release sequence.
rule.extend-neutral-platform-without-competing-with-customers
Preserve neutral core positioning and invest in customer-enabling ecosystem services before considering proprietary downstream products.
Neutrality can broaden participation and design enablement can reduce customer cost, time and risk without requiring the platform to appropriate the customer's branded economics.
Use when
- Customers entrust proprietary designs or data to a shared production platform.
- The platform can improve customer outcomes through tools, interfaces, libraries or partner ecosystems.
- Entering customers' downstream product markets could create a credible conflict.
Do not transfer when
- Customer-level evidence shows neutrality has no retention or win-rate value.
- A proprietary product can be ring-fenced with consent and passes a superior risk-adjusted capital test.
Reverse or kill if
- Stop proprietary activity when it causes material design losses or breaches customer-conflict limits.
- Reassess neutral-only positioning when enablement economics remain persistently negative and no retention benefit is verified.
Limitations and promotion gaps
- The case does not quantify TSMC's customer-trust premium.
- Intel's later integrated strategy is rival context, not a controlled counterexample.
rule.preserve-operating-scope-before-longitudinal-comparison
Preserve each filing vintage and scope, present directional as-reported tables, and abstain from normalized growth or value attribution until a human-approved reconciliation exists.
Silent normalization can manufacture trends, while explicit scope lineage lets decision makers use what is comparable and quarantine what is not.
Use when
- A long series crosses accounting regimes, consolidation scopes, capacity definitions, currencies or unit-equivalence conventions.
- Decision makers could mistake nominal growth for a comparable return measure.
Do not transfer when
- A complete audited or human-approved reconciliation establishes identical definitions and scopes.
Reverse or kill if
- Withdraw a normalized conclusion when its source lineage omits a material scope or currency change.
- Permit the comparison only after an approved reconciliation binds each input and adjustment.
Limitations and promotion gaps
- Directional as-reported tables still contain inflation and currency effects.
- The rule governs evidence quality, not the economic merits of any strategy.
rule.stage-logistics-capacity-around-service-cadence
Approve the location option and continuity design, but release irreversible building, automation, and ramp capacity against stable-scope peak throughput, service cadence, store/selling-area demand, and downside-liquidity gates.
Floor space alone does not create fast response; staged capacity protects cadence and redundancy while limiting the cost of forecast error.
Use when
- Demand-responsive retail depends on a recurring replenishment cadence and short merchandising-feedback loops.
- A proposed logistics hub is large, long-lived, and divisible into land, building, automation, and ramp releases.
- Existing capacity has apparent headroom but also creates concentration or interruption risk.
Do not transfer when
- Phasing would destroy the location option or prevent the minimum viable redundancy architecture.
- Contracted diversified demand and verified peak loads already cover the full module with adequate liquidity.
Reverse or kill if
- Pause a module when stable-scope peak utilization misses the gate and service does not improve.
- Reverse outsourcing or routing changes when cadence, data feedback, continuity, or worker safeguards fall below contract.
Limitations and promotion gaps
- Public evidence does not reveal Zaragoza's actual board gates, project cash flows, or cancellation costs.
- One success case does not establish a cross-industry base rate.
rule.preserve-retail-measurement-scope-before-comparison
Keep each reported fact on its original fiscal, accounting, currency, channel, ownership, and metric definition; disclose conflicts and require a deterministic reconciliation before producing normalized ratios or returns.
Silent scope changes manufacture trends and precision, while explicit unknowns preserve the ability to update when the missing bridge arrives.
Use when
- A retail series crosses accounting regimes, consolidation perimeters, currencies, channels, or ownership models.
- Store count, selling area, like-for-like sales, inventory level, inventory days, and nominal growth are all used in the decision.
- Public sources report conflicting project amounts or internal presentation differences.
Do not transfer when
- An audited reconciliation explicitly bridges the complete series on one definition.
Reverse or kill if
- Withdraw a normalized series if its perimeter, currency, or definition bridge cannot be reproduced.
- Replace an unknown only when the new source retains source-to-output lineage.
Limitations and promotion gaps
- Explicit scope preserves integrity but does not itself produce a comparable economic series.
- The rule does not determine which accounting adjustment is economically best.
rule.price-worker-safeguards-into-hybrid-supply-capacity
Include supplier mapping, worker and union access, purchasing-practice review, grievance, remediation, continuity, and living-wage evidence as funded operating constraints in every capacity or outsourcing decision.
Fast response can externalize volatility and labor harm; access and remedy mechanisms improve detection, while supplier-level outcomes test whether commitments work.
Use when
- Speed depends on external suppliers, workshops, transport, or nearshore capacity.
- Purchasing practices and volatile demand can shift cost or risk to workers and supplier communities.
- A code or framework agreement exists but outcome coverage is incomplete.
Do not transfer when
- The activity is genuinely internal and equivalent worker safeguards and outcome data already cover every affected site.
Reverse or kill if
- Suspend a supplier or capacity route when severe harm lacks timely remedy or access is persistently denied.
- Redesign purchasing gates when the commercial team repeatedly creates unfinanceable or unsafe supplier schedules.
Limitations and promotion gaps
- The IndustriALL agreement documents commitments and mechanisms, not universal compliance.
- Public filings do not provide a complete supplier-level worker outcome panel.
rule.stage-platform-infrastructure-with-cohort-gates
Release the smallest representative tranche and require matched-cohort adoption, fully loaded contribution, service, loss, and legal-entity liquidity to pass predeclared gates before scaling.
A staged partner or market-cell design purchases information about both ecosystem uplift and hidden operating cost while preserving reversal rights.
Use when
- A platform is filling missing transaction infrastructure through a commitment that can be divided by country, route, cohort, partner, or capital tranche.
- The proposed complement may improve network engagement but standalone contribution, service, and retention effects are uncertain and measurable.
Do not transfer when
- Delay would destroy a scarce network or regulatory opportunity whose quantified cost exceeds the expected information value.
- No representative and timely test is possible, or immediate action is required to stop an existing safety, custody, or liquidity loss.
Reverse or kill if
- Stop subsequent releases after two unresolved service or contribution gate failures.
- Re-underwrite when the relevant legal entity breaches its stressed liquidity floor.
- Reverse if observed engagement uplift disappears after controlling for promotion, seller, category, route, and price.
Limitations and promotion gaps
- Partner-based staging may not transfer to indivisible infrastructure.
- Cohort estimates can be contaminated by selection, promotions, seasonality, and network spillovers.
- The public record does not reveal MercadoLibre’s actual board gates.
rule.preserve-platform-metric-perimeters
Version every metric definition and perimeter, block silent joins, and show explicit bridges or unknown cells before computing growth, take rate, penetration, unit economics, or causal contribution.
Denominator, scope, presentation, and perimeter changes can manufacture apparent growth or margin improvement that is not an economic change.
Use when
- Analysis spans multiple platform products, geographies, currencies, or reporting vintages.
- Metrics such as GMV, TPV, marketplace TPV, revenue, items, users, credit, or shipping coverage have different or changing definitions.
Do not transfer when
- The issuer supplies a verified stable-scope recast that exactly covers the requested comparison.
Reverse or kill if
- Withdraw any inference built on a denominator or perimeter later shown to be inconsistent.
- Recompute the decision packet whenever a recast or discontinued KPI changes the comparison.
Limitations and promotion gaps
- Even stable definitions do not establish causality.
- Issuer recasts may still omit inflation, constant-currency, cohort, or legal-entity normalization.
rule.separate-ecosystem-scale-from-standalone-value
Recognize the mechanism as a hypothesis, but abstain from assigning all aggregate revenue, profit, enterprise value, or market value to the complement until a capitalization-complete causal bridge exists.
Payments, logistics, credit, advertising, macro conditions, competition, and later execution can reinforce one another, making aggregate endpoint attribution non-identifiable.
Use when
- A platform complement scales alongside the broader ecosystem.
- Standalone cash flow, capital, subsidies, working capital, and attribution are unavailable or definition changes are material.
Do not transfer when
- A controlled decomposition and standalone financial record identify incremental cash flows, capital, risk, and counterfactual performance.
Reverse or kill if
- Withdraw project-value attribution when standalone inputs or the counterfactual fail audit.
- Reclassify a claimed moat benefit if regulation, seller dependence, service harm, or credit losses materially change the economics.
Limitations and promotion gaps
- A complement can be strategically essential even when its standalone accounting contribution is negative.
- Controlled attribution is difficult where network effects spill across cohorts.
rule.wirecard.verify-cash-four-rights
Obtain direct independently controlled confirmation and prove existence, legal ownership or beneficial interest, restrictions, customer or counterparty obligations, entity location, and practical access before netting cash against debt or funding new capital.
A balance can exist yet be unavailable, belong economically to another party, be restricted, or be supported by a compromised confirmation channel; gross consolidation does not answer those separate questions.
Use when
- Reported cash is material to solvency, net debt, valuation, covenant headroom or an investment recommendation.
- Any material balance is held through a bank, trustee, customer-fund structure, foreign entity or other third party.
Do not transfer when
- The balance is demonstrably immaterial under a preapproved threshold and excluding it cannot change the decision.
Reverse or kill if
- Suspend valuation and new exposure if confirmations are delayed, routed through management or trustees without independent control, or conflict with statements or legal rights.
- Reduce or exit if a material balance fails existence, ownership, restriction or access testing and the downside cannot be bounded promptly.
Limitations and promotion gaps
- Confirmation proves only its date, account and respondent scope; subsequent transfers, fraud, legal disputes and operational access can still change availability.
- Bank cash, customer funds, trustee assets and restricted collateral require different legal and accounting analyses.
rule.wirecard.trace-third-party-economics
Trace an independently selected and risk-weighted population from genuine customer or merchant identity and contract through operational record, delivery, settlement, receivable, recognized revenue and cash or other economic benefit to the correct legal entity.
Aggregated reports and counterparty summaries can preserve a plausible total while hiding nonexistent participants, aliases, circular activity, attribution errors, missing settlement or economics belonging to another party.
Use when
- Material revenue, EBITDA, receivables or cash depend on third-party processors, acquirers, distributors, resellers, trustees or counterparties.
- Management cannot produce a complete internally controlled source-to-cash chain for the population.
Do not transfer when
- Independently controlled population-level systems and confirmations already provide equivalent or stronger end-to-end assurance with tested access and change controls.
Reverse or kill if
- Stop relying on reported third-party economics if requested populations cannot be produced in a reproducible form.
- Reduce exposure if material exceptions persist beyond the predeclared cure window or expand under independent sampling.
Limitations and promotion gaps
- Sampling can miss coordinated or low-frequency problems; population analytics and independent selection remain necessary.
- A valid transaction may still be unprofitable, concentrated, reversible or attributed to the wrong entity.
rule.wirecard.scope-assurance-signals
Map the signal to its issuer, date, procedures, population, materiality, legal entity, exceptions and explicit noncoverage; require primary verification for any decision-critical assertion outside that scope.
Assurance and regulatory signals answer bounded questions. Scope substitution converts evidence of one proposition into false confidence about another.
Use when
- An audit opinion, regulatory action, investigation, rating or market price is offered as reassurance about a different underlying risk.
Do not transfer when
- The signal's documented scope and procedures directly cover the exact assertion, period, entity and population at issue and no contradictory evidence remains.
Reverse or kill if
- Remove or downgrade support when the signal's actual scope is narrower than the assertion.
- Escalate immediately when component gaps, confirmation failures, investigation obstacles or omitted qualifications affect a decision-critical population.
Limitations and promotion gaps
- Even a direct scope match provides assurance only to the procedures, date and materiality used.
- Market and regulatory signals can contain useful information despite not being verification substitutes.
rule.wirecard.stage-capital-under-authenticity-risk
Cap exposure at a predeclared observation level, prohibit additions, purchase the missing evidence with dated gates, and specify automatic reduction or exit triggers before uncertainty resolves.
Divisible capital preserves learning and upside optionality while preventing favorable narratives, price recovery or sunk cost from increasing exposure to an unbounded authenticity tail.
Use when
- A decision has asymmetric permanent-loss exposure if a decision-critical balance or earnings stream is inauthentic.
- Primary verification is incomplete, but immediate full exit is not required by liquidity, safety, fiduciary or mandate constraints.
Do not transfer when
- Waiting creates unacceptable customer-safety, custody, liquidity, legal or fiduciary risk; in that case use the faster protective action required by the constraint.
- Exposure cannot be resized safely because trading is closed, assets are locked or execution itself would violate a superior duty.
Reverse or kill if
- Increase only after all predeclared primary-evidence, liquidity and governance gates pass independently.
- Exit rather than wait if evidence access is denied, verification failures spread, funding remedies accelerate or the observation cap is breached.
Limitations and promotion gaps
- A staged position still loses money if the severe case arrives before exit; it is risk control, not insurance.
- Some cases require immediate action rather than evidence purchase, especially fast funding runs, custody failures and safety hazards.
rule.wirecard.preserve-reporting-vintage-and-scope
Preserve the original and later records as separate dated facts, link true supersession explicitly, and compare amounts only after reconciling period, entity, category, currency, unit and evidentiary posture.
Silent overwrite creates hindsight leakage; false reconciliation makes distinct balances appear identical and can exaggerate or conceal the mechanism.
Use when
- A later comparative, restatement, nullity finding, investigation amount or management reassessment differs from an earlier reported value.
Do not transfer when
- The later source explicitly provides a complete same-scope replacement and the original remains retained in immutable lineage.
Reverse or kill if
- Withdraw any table or causal statement that cannot reconcile the compared amounts' periods and categories.
- Restore the original record if a later value has been used to rewrite what was knowable at the decision cutoff.
Limitations and promotion gaps
- A revision chain can remain legally or economically disputed even when its documentary lineage is complete.
- Preserving a value does not validate its accuracy; it preserves what the source reported and when.
rule.ftx.custody-verification-gate
Cap balances at operational need and withdraw excess exposure in verified stages until the custodian passes an entity-specific asset-control and liquidity reconciliation.
Contractual title does not itself prevent operational access or commingling; custody loss severity is asymmetric when verification fails.
Use when
- A centralized platform holds material customer assets.
- A related proprietary affiliate can create correlated balance-sheet or conflict risk.
- Complete entity-specific liabilities asset control encumbrances and related-party permissions are not independently reconciled.
Do not transfer when
- Bankruptcy-remote segregation and full liquid coverage are independently and frequently reconciled for the exact legal entity and account product
Reverse or kill if
- Cross-case testing shows entity-specific custody verification does not improve loss avoidance or creates greater execution risk than the exposure it controls
Limitations and promotion gaps
- One failure cannot calibrate a universal balance cap or proof frequency; account terms and withdrawal mechanics differ.
rule.ftx.self-referential-collateral
Exclude the exposure from immediately liquid resources until independently executable depth is proven and stress price decline collateral calls and withdrawals simultaneously.
Selling to meet obligations can depress the same instrument supporting collateral and reported equity producing a reflexive liquidity spiral.
Use when
- A company's or affiliate's reported resources materially depend on a token or instrument created or supported by the same corporate group.
- Ownership concentration or executable market depth can make reported value endogenous to confidence in the group.
Do not transfer when
- Deep independent market liquidity and dispersed ownership support verified liquidation without material feedback
Reverse or kill if
- Cross-case evidence shows issuer-linked collateral remains independently liquid and does not amplify funding stress
Limitations and promotion gaps
- The cutoff leak was partial and unaudited; the rule requires calibration across liquid and illiquid instruments.
rule.ftx.entity-perimeter
Attribute every protection and resource to its exact legal entity product and jurisdiction and require an enforceable transfer or guarantee before using it elsewhere.
Group branding and shared management do not make a regulated subsidiary's assets legally or operationally available to another customer perimeter.
Use when
- A group markets under one brand but contracts through multiple legal entities.
- Capital segregation insurance licenses or liquidity evidence is disclosed for only one entity or product.
Do not transfer when
- An enforceable independently verified guarantee or consolidation makes the resource available under the relevant failure scenario
Reverse or kill if
- Legal and operational testing demonstrates that the group-level resource remains available across the modeled insolvency perimeter
Limitations and promotion gaps
- Cross-border insolvency and contract enforceability require qualified human legal review.
rule.patient-facing-assay-validation-gate
Pause the unsupported workflows, preserve records and specimens, and allow patient use only after independent blinded validation and quality-system gates clear for every offered combination.
Assay- and workflow-specific gates prevent narrow evidence from being extrapolated across heterogeneous tests and stop unresolved quality failures from propagating through patients, partners, regulators, and capital providers.
Use when
- A product produces patient-facing or safety-critical decisions with asymmetric downside from false results.
- Commercial claims or rollout scope exceed independently verified assay-, specimen-, device-, site-, operator-, or workflow-specific evidence.
- A pause, ring-fence, or staged validation program remains operationally feasible.
Do not transfer when
- A verified emergency-use pathway expressly permits the use and the residual risk is independently documented and disclosed.
- The allegedly unsupported workflow can be proven outside the gate's scope with immutable, independently reproduced evidence.
Reverse or kill if
- Relaunch only the combinations that clear predeclared analytical, clinical, specimen, device, site, operator, and quality-system criteria.
- Kill the broader program if critical records are unavailable, remediation cannot be independently verified, or liquidity cannot support safe completion.
- Narrow this rule if cross-case testing shows that mandatory full-workflow gating causes greater patient harm than bounded use under a verified emergency pathway.
Limitations and promotion gaps
- A single failure case cannot identify optimal thresholds, duration, cost, or the value of a pause.
- Full validation coverage is a safety gate, not evidence that a business model or valuation is attractive.
- The Theranos public record cannot quantify how much failure arose from device performance versus collection, processing, laboratory operations, governance, financing, or misconduct.
rule.preserve-legal-and-measurement-status
Preserve each proposition's legal and epistemic status and prohibit additive financial or causal conclusions until an independently reconciled bridge proves compatibility and non-overlap.
Status and measurement separation prevents allegations from becoming findings, defendant-specific verdicts from becoming enterprise-wide conclusions, and heterogeneous monetary records from becoming a fabricated loss estimate.
Use when
- A business-failure analysis combines regulator observations, complaints, consent judgments, verdicts, appellate holdings, company estimates, or monetary remedies.
- The records concern different entities, dates, legal burdens, or measurement bases.
Do not transfer when
- A controlling adjudication or audited reconciliation expressly supersedes the earlier status and maps every amount to compatible entities, dates, and concepts.
Reverse or kill if
- Correct or withdraw any conclusion whose pleaded, consented, acquitted, convicted, affirmed, estimated, or audited status was misstated.
- Permit aggregation only after deterministic reconciliation proves identical scope, compatible measurement bases, and no overlap.
Limitations and promotion gaps
- Status discipline does not determine intent, liability, technical causation, or enterprise loss by itself.
- Public dockets may omit sealed, superseded, or later-corrected records.
rule.kodak.separate-capability-from-economics
Build separate evidence chains for invention capability, commercialization activity, and stable-cohort gross profit, free cash flow, and return before assigning transition value.
Technical foresight and revenue growth create options, but value depends on customer use, unit economics, reinvestment, competitive capture, and timing.
Use when
- A company cites patents, technical milestones, product launches, or category growth as proof that it can navigate a platform transition.
- The new business uses different price, margin, working-capital, support, channel, or capital economics from the legacy business.
Do not transfer when
- A complete audited product-cohort ledger already reconciles technical milestones to after-tax cash returns.
Reverse or kill if
- Reverse a positive transition judgment if revenue growth persists without contribution and cash conversion.
- Kill a cohort after two predeclared gate failures without a verified transient cause or strategic option value.
Limitations and promotion gaps
- One case cannot establish universal thresholds.
- Public segment reporting may be too coarse for product-cohort inference.
rule.kodak.require-value-crossover
Require a value-crossover bridge showing recurring new-business gross profit and after-tax free cash flow replacing lost legacy cash after all transition and liability costs.
Revenue can cross over while margin, cash conversion, and return remain inadequate, creating a false milestone during disruption.
Use when
- Management declares that new-business revenue has crossed over legacy revenue.
- Legacy gross profit and cash fund restructuring, liabilities, distributions, or new-business investment.
Do not transfer when
- Revenue is contractually equivalent to cash and requires no material incremental cost or capital
- which must be demonstrated rather than assumed.
Reverse or kill if
- Withdraw the crossover conclusion when non-recurring licensing, asset sales, acquisitions, or classification changes create the apparent bridge.
- Re-underwrite if legacy decline accelerates faster than fixed-cost and liability cash can adjust.
Limitations and promotion gaps
- The Kodak public record does not provide a complete historical product-level value bridge.
- The appropriate cash and return thresholds depend on contracts and capital structure.
rule.kodak.stage-disruption-capital
Release reversible capital tranches behind product-return, integration, legacy-cash, stakeholder, and liability-aware liquidity gates while preserving licensing, partnership, sale, and shutdown options.
Staging buys information and protects the cash bridge when new economics can disappoint before old obligations disappear.
Use when
- A disruptive transition requires simultaneous product investment, acquisitions, restructuring, and legacy-liability funding.
- Product economics, integration outcomes, and substitution speed are uncertain but observable over time.
Do not transfer when
- Delay destroys a scarce opportunity whose quantified cost exceeds the information and liquidity value of staging.
- Contractual indivisibility makes a representative tranche infeasible and the full downside still clears liquidity and return gates.
Reverse or kill if
- Stop acquisitions when prior cohorts do not reconcile to promised cash and return milestones.
- Accelerate legacy cost actions when demand and utilization breach matched downside bands.
- Shift to licensing, partnership, sale, or closure when owned economics cannot clear the return floor.
Limitations and promotion gaps
- Historical contracts and cost-of-delay evidence are missing.
- Staging cannot eliminate disruption risk and may itself sacrifice speed.
rule.protect-fixed-ratio-merger-currency
Condition approval on a documented collar, repricing mechanism, delayed-close or walk right, and a common-perimeter capitalization bridge; if those protections are unavailable, prefer a staged partnership or smaller reversible stake until relative economics are verified.
A fixed ratio transfers counterparty share-price risk to the seller's holders, while reversible structures preserve learning and bargaining power before full ownership and integration costs become sunk.
Use when
- A stock-for-stock transaction uses a fixed exchange ratio and the counterparty's equity is a material portion of consideration.
- Relative operating contribution, market-equity contribution, and proposed ownership differ materially or depend on incomparable measures.
- The counterparty's valuation or accounting quality is uncertain enough that price movement can alter delivered value before closing.
Do not transfer when
- The holders deliberately seek full exposure to the counterparty equity and a downside stress remains attractive on audited common-basis economics.
- Binding protections or a demonstrably stable and fully reconciled relative-value structure already limits the same risk.
Reverse or kill if
- The collar, walk right, or other protection ceases to cover the board-approved downside case.
- A capitalization, accounting, or revenue-quality gap prevents common-basis relative valuation.
- Regulatory delay materially changes business conditions before closing without a re-underwriting right.
- A smaller or contractual alternative preserves most expected economics with materially less irreversible exposure.
Limitations and promotion gaps
- Candidate status reflects one reconstructed case and requires cross-case validation.
- A collar can reallocate risk but cannot repair an unattractive business combination or guarantee intrinsic value.
- The case does not estimate an optimal collar width or counterparty willingness to renegotiate.
rule.verify-synergy-before-full-integration
Run staged commercial tests and release ownership or integration commitments only against an independently reviewed net cash synergy ledger with frozen standalone baselines, stable definitions, customer-level evidence, required investment, and explicit stop conditions.
Staging distinguishes incremental third-party economics from intercompany activity, presentation effects, inherited contracts, and external growth while preserving the option to stop before organizational and systems costs become irreversible.
Use when
- A transaction thesis depends materially on revenue, distribution, customer, technology, or cost synergies across distinct operating systems.
- Public forecasts do not reconcile the synergy baseline, gross profit, cash collection, cost to achieve, dis-synergies, and accountable owner.
- Many claimed benefits can be tested through contracts, pilots, a minority stake, or modular integration releases.
Do not transfer when
- Delay would destroy a separately evidenced opportunity whose value exceeds the tested downside under binding protection.
- The economics are already contractually guaranteed by creditworthy third parties and net of all material costs and dis-synergies.
Reverse or kill if
- Net cash synergies remain below the approved gate for two review periods after definition and perimeter reconciliation.
- Intercompany, inherited-contract, noncash, or gross-presentation items dominate the claimed realization.
- Customer, talent, regulatory, control, or systems dis-synergies exceed the approved envelope.
- A partnership or separation preserves valuable activity with better risk-adjusted economics.
Limitations and promotion gaps
- The rule does not assume that all synergies are measurable immediately or that legal ownership never adds value.
- Interim commercial activity is not automatically net incremental synergy, and later separation does not make interim synergy zero.
- Candidate status reflects one case; pilots and gate thresholds require industry-specific calibration.
rule.separate-accounting-write-down-from-value-causality
Preserve every reported basis and vintage, reconcile accounting and cash-flow endpoints deterministically, and abstain from all-value attribution or causal percentages until capitalization, distributions, market returns, counterfactual performance, and confounders are source-complete.
Accounting remeasurement can contain economic information without being a contemporaneous cash payment, while mixed perimeters and co-causes make salient-event arithmetic an unreliable measure of shareholder loss or causal responsibility.
Use when
- A transaction is followed by large goodwill or intangible impairment, restatement, changing segment perimeters, or non-GAAP operating measures.
- Analysts seek to equate a write-down, headline deal value, market-capitalization change, enterprise value, cash loss, or shareholder return.
- Multiple macroeconomic, competitive, regulatory, strategic, governance, culture, execution, or accounting mechanisms affect the same outcome.
Do not transfer when
- An audited deterministic bridge establishes identical basis and directly identifies the full cash and counterfactual return effect.
- No material perimeter, accounting, market, or causal confounder exists.
Reverse or kill if
- A later filing revises the amount, scope, or noncash classification.
- A perimeter or definition break cannot be reconciled.
- Counterfactual market returns lack complete prices, capitalization, distributions, and benchmark treatment.
- The proposed causal claim cannot survive a documented rival hypothesis.
Limitations and promotion gaps
- This rule improves attribution discipline but does not itself calculate intrinsic value or identify the optimal counterfactual.
- An impairment may still be decision-useful evidence about prior expectations even though it is noncash.
- Culture and governance mechanisms require direct evidence before being treated as established causes.
rule.wells.kpi-authorization-gate
Stop using the KPI for compensation capital allocation or valuation until representative independent sampling passes board-approved error concentration durability and contribution gates.
A volume target can reward invalid openings and contaminate the metric used to judge success when escalation and enterprise controls do not constrain local incentives.
Use when
- A compensated volume KPI is presented as evidence of customer relationship depth or business quality.
- Customer complaints employee discipline overrides or product reversals suggest products may be unauthorized unused or low value.
- The KPI is not independently reconciled to authorization durable use customer benefit and net contribution by incentive cohort.
Do not transfer when
- Independent representative testing continuously reconciles authorization durable use customer value and contribution and shows no material incentive-linked exception concentration
Reverse or kill if
- Cross-case testing shows the gate does not distinguish customer-valid KPIs from ordinary complaint and discipline noise or creates greater decision cost than the risk controlled
Limitations and promotion gaps
- One case cannot calibrate universal error thresholds sampling frequency or expected financial impact; near-zero and material are uncalibrated governance placeholders; human accounting conduct and publication review remain required.
rule.stage-customer-co-investment-by-workstream
Structure customer co-investment as non-exclusive, independence-preserving workstreams; release capital separately against independent technical qualification, net-funding, binding-demand, and customer-acceptance gates, with explicit pause and reallocation rights.
Customer funding can share technical risk and expose demand information, while workstream modularity and governance safeguards preserve the option to stop a weak demand path without abandoning a technically progressing platform.
Use when
- A supplier faces frontier-technology programs whose technical and demand risks can be separated into workstreams.
- Strategic customers are willing to fund R&D or invest capital but may also seek pricing, access, voting, exclusivity, or roadmap concessions.
- Project-level schedule, production economics, and counterfactual returns remain uncertain.
- The supplier can measure technical qualification and binding customer demand before releasing later tranches.
Do not transfer when
- The required development is technically indivisible across workstreams.
- Customer participation would transfer roadmap control, shared IP, voting power, exclusivity, or unpriced commercial concessions.
- Independent milestone verification is infeasible or customer funding cannot be reconciled net of discounts and remedies.
- A safety, legal, liquidity, or supply constraint makes the proposed learning envelope unacceptable.
Reverse or kill if
- Independent technical qualification misses two consecutive precommitted gates without a credible bounded recovery plan.
- Binding demand is absent or materially deferred beyond the approved option window.
- Net customer funding no longer compensates for incremental cost and commercial concessions.
- Governance changes impair roadmap, IP, voting, or product-access independence.
- Management cannot maintain separate ledgers and decisions for technically distinct workstreams.
Limitations and promotion gaps
- One observational episode cannot establish a universal causal return to customer co-investment.
- The public record establishes completed equity steps, partial contribution accounting, and Intel contractual abandonment and redirection rights, but does not reconcile cumulative NRE cash receipts, workstream spending, net participant concessions, project cash flows, transaction return, or ASML's exact internal gates.
- EUV and 450mm produced different observable paths, so the rule depends on workstream separability.
- The rule does not specify an optimal equity amount, project return, market value, or target price.
rule.stage-recurring-revenue-migration-by-cohort
Sequence irreversible product, channel, price, and legacy-support changes behind predeclared customer-value, mature-cohort retention, fully loaded contribution, and cash-conversion gates.
A staged architecture preserves product focus while purchasing information about durability, containing customer-trust damage, and limiting cash exposure when headline adoption masks weak cohort economics.
Use when
- An incumbent is moving customers from an upfront or perpetual model to recurring access while continuing to deliver material product value.
- Early adoption is observable, but mature renewal, voluntary churn, realized pricing, customer value, and fully loaded cohort contribution remain uncertain.
- The incumbent has enough liquidity or cash generation to preserve a bounded legacy option while evidence matures.
Do not transfer when
- Delay would forfeit a scarce distribution or standards position whose evidenced cost exceeds the information value of staging.
- Maintaining the legacy option would create unacceptable security, regulatory, interoperability, or support risk that cannot be bounded.
- Cohort definitions cannot be kept stable enough for the gates to be decision-useful.
Reverse or kill if
- Pause further legacy withdrawal after two consecutive mature-cohort retention or customer-value gate failures.
- Reprice, redesign, or restore a bounded legacy or long-term-offline option for segments that fail customer-value or contribution gates.
- Re-underwrite the migration if stable fully loaded cohort contribution remains negative after the declared maturation period.
- Slow migration spending if transition-adjusted cash conversion breaches the approved liquidity floor.
Limitations and promotion gaps
- One observational case cannot validate a cross-case rule or identify the value created by a specific gate architecture.
- Adobe's later aggregate results do not disclose whether management actually used these gates.
- The case does not show that forcing every customer into one delivery model is optimal.
- The paired Kodak episode has not been adjudicated here as a counterexample to this exact rule.
- No numeric expected range is supplied because the packet contains no calibrated base rate or causal effect estimate.
rule.volkswagen.regulator-notice-crisis-gate
Establish an independently reporting board crisis authority, preserve the independently defined evidence population, reconcile every potentially shared configuration to regulator evidence, control quantitative disclosures, and map non-overlapping liquidity exposures before material remedy or settlement commitments.
Open technical and legal scope creates asymmetric risk from lost evidence, premature narrowing, inconsistent disclosures, and overlapping commitments; a board-controlled gate preserves information and financing options while facts are reconciled.
Use when
- A public regulator notice alleges that software or another control behaves differently in certification testing and ordinary operation.
- The regulator says its investigation or affected-product scope remains open.
- The issuer has not independently reconciled investigation authority, evidence custody, affected configurations, disclosure obligations, and liquidity exposure.
Do not transfer when
- An independent regulator-witnessed review already verifies complete evidence custody, product scope, disclosure controls, and downside funding.
- A narrowly tailored emergency safety action cannot await the gate; the action should proceed while preservation and reconciliation run in parallel.
Reverse or kill if
- Withdraw or narrow the rule if cross-case testing shows that the trigger produces frequent costly escalations without improving evidence integrity, scope accuracy, disclosure quality, or financing option value.
- Reopen every scope or release decision when independent testing finds an unexplained configuration or regulator mismatch.
- Halt nonessential commitments when the non-overlapping downside bridge breaches a human-approved minimum liquidity buffer or relies on uncommitted funding.
Limitations and promotion gaps
- This is a candidate from one retrospective case and is not corpus-validated.
- The 24-hour and 100% preservation threshold is a precautionary analyst-designed gate, not a threshold calibrated from a reference class.
- The rule governs response after a public regulator notice; it does not prevent or explain the underlying misconduct.
- Investigation authority, accounting adjustments, legal conclusions, publication, and external commitments still require appropriate human approval.
rule.turnaround.sequence-customer-value-cost-and-cash
Begin customer-value repair alongside only controller-owned action-register cost removals that preserve predeclared customer, service, and availability floors; release footprint, digital, and capital tranches only after stable customer outcomes, gross-profit dollars, gross-to-net cash savings, omnichannel contribution, and downside liquidity clear predeclared gates.
Sequencing lets management test whether price, service, store, and digital changes repair demand without destroying contribution, while cash reconciliation prevents announced savings from being counted twice or spent before realization.
Use when
- A retailer faces simultaneous customer-value, comparable-sales, and margin pressure.
- Existing stores, service capabilities, customer relationships, and digital demand may be recombined rather than abandoned wholesale.
- Announced savings, channel growth, and liquidity are not yet reconciled to fully loaded contribution and cash.
Do not transfer when
- Delay would forfeit a demonstrably scarce opportunity whose expected loss exceeds the information value of staging.
- Fully loaded contribution and downside liquidity are already independently verified under a severe but plausible stress case.
Reverse or kill if
- Stop a customer-value action when controlled cohorts fail to improve gross-profit dollars or breach service and return ceilings.
- Reverse a cost action that lacks controller-owned action-register support or breaches a predeclared customer, service, or availability floor; stop counting or reinvesting a saving that does not reconcile from announced run rate to realized net cash benefit.
- Stop channel scaling when mature cohorts remain contribution-negative beyond the approved payback window.
- Pause optional investment and capital returns when stressed liquidity breaches the predeclared floor.
Limitations and promotion gaps
- The Best Buy public record does not reveal whether the Part A gate protocol or its analyst-designed two consecutive monthly capital gates were used.
- One observational success case cannot identify the optimal cadence or thresholds for other retailers.
- Category cycles, competition, scope changes, and later execution remain live rival explanations.
rule.preserve-filing-vintages-with-known-scope-change
Preserve each filing-vintage fact, label its scope and public-availability time, cite the disclosed basis change, and compare only within an explicitly selected vintage or reconciled perimeter.
Filing-vintage lineage prevents later presentations from overwriting what was publicly knowable and keeps accounting-scope changes from being misclassified as operating performance.
Use when
- Successive authoritative filings present materially different values for the same issuer, metric, and economic period.
- A filing identifies discontinued operations, classification changes, fiscal-calendar differences, or another scope change affecting comparability.
Do not transfer when
- The later filing provides a complete reconciliation and the analysis explicitly selects that reconciled basis for every compared period.
Reverse or kill if
- Withdraw a trend calculation when a later source reveals an unmodeled perimeter, classification, or fiscal-calendar difference.
- Replace separate-vintage presentation only after the reconciliation itself has source-to-output lineage.
Limitations and promotion gaps
- Materiality is decision-specific, and minor vintage differences do not block every qualitative conclusion.
- A disclosed scope change can explain why values differ without supplying every line needed for a complete bridge.
rule.require-prelaunch-controls-or-cap-customer-exposure
Do not authorize a broad reset until representative controls and rollback are demonstrated; choose pause and diagnose or cap exposure through time-, category-, customer-, or store-sequenced tests under a tighter board-set downside-liquidity limit.
Capped exposure preserves an observable counterfactual and limits inventory, communication, margin-dollar, and cash damage while management learns whether the new customer promise is understood and economically viable.
Use when
- A customer-facing price or promotion architecture would change broadly before its demand, gross-margin-dollar, inventory, and cash effects are measured.
- Representative customer, store, category, or time controls and operational rollback are not yet demonstrated.
- Downside liquidity depends on customer acceptance or on internally generated cash funding concurrent transformation work.
Do not transfer when
- Delay creates a documented irreversible loss whose expected cost exceeds the information and option value of staging.
- A representative test is impossible, but a bounded time or category release with verified rollback and independently stressed liquidity is feasible.
Reverse or kill if
- Stop expansion when a material cohort breaches its predeclared customer, gross-margin-dollar, inventory, or cash band without a verified transient cause.
- Revert to pause and diagnose when rollback fails a production-like control test.
- Reduce exposure and commitments when downside liquidity breaches the tighter board-set floor.
Limitations and promotion gaps
- The public record does not establish whether representative nationwide price tests or a clean promotion rollback were operationally feasible.
- One failure case cannot calibrate universal cohort coverage, review windows, or liquidity thresholds.
- Best Buy is a paired contrast, not a controlled counterfactual; retailer economics, timing, and interventions differed.
rule.separate-customer-policy-reset-from-format-rollout
Underwrite the immediate customer-policy reset separately from phased physical-format and systems tranches, predeclare stable cohorts where feasible, and require each workstream to earn expansion on its own customer, contribution, execution, and liquidity evidence.
Separate release clocks and stable scopes preserve attribution and prevent a promising local format claim from offsetting unmeasured companywide customer or cash deterioration.
Use when
- Pricing or promotion changes reach most customer transactions quickly while shops, formats, systems, or capital programs roll out on different calendars.
- Management needs to identify which workstream changed demand, gross-margin dollars, inventory, and cash.
- Aggregate company results would combine price-only, format-only, combined, and untreated exposures.
Do not transfer when
- Contract, systems, brand, or customer-communication evidence shows separation would create greater expected harm than a combined but tightly capped test.
Reverse or kill if
- Stop a workstream that fails its own stable-cohort customer, contribution, execution, or cash gate.
- Withdraw causal attribution when exposure clocks, populations, or accounting scope cannot be reconciled.
- Do not use shop productivity to override companywide deterioration without a reconciled transfer and contribution bridge.
Limitations and promotion gaps
- Workstreams may be operationally coupled even when their public launch calendars differ.
- Shop-level productivity can coexist with companywide deterioration for reasons including transfer, mix, incomplete rollout, or external pressure.
- The case does not identify the optimal number or duration of cohorts.
rule.stage-pivotal-validation-and-at-risk-scale
Launch the pivotal validation program and stage at-risk manufacturing in parallel; release each scale tranche only when trial integrity, safety, net funding, technology transfer, yield, batch release, logistics and demand gates remain inside the approved downside envelope.
Parallel work can preserve scarce deployment time while a falsifiable pivotal test prevents an early surrogate signal or funding commitment from becoming assumed endpoint proof; staged tranches preserve the option to stop when evidence or conversion economics deteriorate.
Use when
- Early evidence supports a bounded pivotal test but does not establish the clinically or commercially decisive endpoint.
- A prespecified pivotal protocol can decisively falsify the product thesis within a useful decision window.
- Manufacturing or deployment lead time is valuable and cannot be fully recovered after the pivotal readout.
- Development, trial and scale exposures can be separated into auditable tranches with measurable company-funded and externally funded downside.
Do not transfer when
- The pivotal endpoint or statistical governance cannot produce decision-relevant evidence.
- Manufacturing exposure cannot be separated from an uncapped enterprise-threatening commitment.
- Quality, raw-material, fill-finish, regulatory-release or logistics constraints make pre-readout capacity economically unusable.
- External funding or procurement conditions cannot be distinguished from unconditional cash and normalized demand.
Reverse or kill if
- Pivotal evidence fails the prespecified efficacy or safety gate or becomes uninterpretable.
- Net company-funded exposure exceeds the approved downside envelope after verified external reimbursements and cancellation rights.
- Technical transfer, yield, quality release, fill-finish or logistics repeatedly miss the tranche plan without a credible remediation path.
- Apparent demand depends on cancellable commitments, customer financing or deposits whose obligations overwhelm expected contribution economics.
- Management substitutes a surrogate response, award ceiling, capacity announcement or descriptive analyst calculation for authoritative endpoint or cash-flow evidence.
Limitations and promotion gaps
- Candidate status reflects one supporting episode and no adjudicated counterexample; cross-case validation is required before promotion.
- The public outcome record does not establish that Moderna used the rule's internal tranche and gate architecture; those controls are prescriptive rather than a recovered historical process.
- The episode does not estimate an optimal tranche size, funding mix, capacity commitment or risk-adjusted return.
- Extraordinary pandemic demand, emergency regulation, public funding and procurement materially limit generalization to normal product markets.
- Later public evidence supports historical outcome classification but does not make the rule or a security valuation knowable at the cutoff.
rule.curevac.stage-scale-behind-pivotal-gates
Run the decisive validation while staging later irreversible scale behind predeclared evidence and timing gates.
Staging preserves information and upside while reducing stranded-capacity and termination exposure if the product is statistically modest, delayed, or not regulatorily acceptable.
Use when
- A product requires a decisive pivotal test before regulatory and commercial validation.
- Manufacturing or supply commitments become materially costly or difficult to reverse before that test resolves.
- Clinical, quality, regulatory, and timing milestones can be observed before later commitment tranches.
Do not transfer when
- The option cost of delay demonstrably exceeds the downside protected by staging.
- Representative validation cannot occur before capacity must be reserved.
- Contract evidence proves that staging is infeasible.
Reverse or kill if
- Stop the next scale tranche if the pivotal or quality gate fails.
- Redirect the first-generation program if expected authorization misses the addressable procurement window.
- Escalate for human approval when termination exposure exceeds the approved downside budget.
Limitations and promotion gaps
- One case cannot validate a cross-case rule.
- The public record does not quantify the cost of delayed capacity or contract-by-contract reversibility.
rule.curevac.separate-conditional-support-from-sales
Model each cash receipt, contract liability, accounting release, option, and delivered-dose sale as a separate state-contingent item.
Separating cash timing and accounting classification prevents conditional support from masquerading as recurring product demand or unit economics.
Use when
- Government funding or advance-purchase support depends on clinical, regulatory, supply, or milestone conditions.
- Accounting releases or upfront cash can appear in reported income or cash before delivered product economics exist.
Do not transfer when
- Authoritative contract and accounting records establish unconditional, non-refundable delivered-product revenue.
Reverse or kill if
- Reverse the revenue classification if delivery or recognition evidence is absent.
- Reclassify the forecast when a milestone, approval, or supply condition fails.
Limitations and promotion gaps
- Public summaries may omit refund, cancellation, and committed-cost terms.
- Accounting income can be economically relevant without being recurring product revenue.
rule.preserve-local-platform-and-stage-acquisition-integration
Preserve the target's accountable local operating core and separately measured economics; integrate mandatory controls first, then shared supply or distribution interfaces, and release deeper brand, product, data or platform consolidation only after owner-approved service-health, cash-conversion, incremental-contribution and reversibility gates pass for two consecutive reviews; if attribution or cash conversion remains unresolved after four quarterly reviews or 12 to 18 months, pause deeper integration and re-underwrite the ownership and operating model.
Modular integration can capture shared supply and distribution benefits while limiting disruption to the target's compounding engine; stable ledgers, precommitted gates and independent review keep target momentum, external tailwinds and integration contribution from being conflated.
Use when
- An acquisition's value thesis depends on a target's locally adapted supply, customer relationships, operating team or product engine continuing to compound after closing.
- Shared inventory, controls or distribution can be integrated modularly without immediately replacing every brand, product or technology platform.
- Public or diligence evidence cannot yet isolate stable-perimeter target cash flows, integration costs and incremental acquirer-side contribution.
Do not transfer when
- Immediate consolidation is required by law, safety, financial-control remediation or a separately evidenced existential platform risk.
- Contractually committed and independently verified synergies exceed the staged alternative after all integration costs, dis-synergies and downside cases.
Reverse or kill if
- Target cash conversion or platform health remains outside approved bands for two consecutive reviews after data-quality checks.
- Shared-distribution net contribution remains below the approved gate or cannot be separated from standalone momentum, FX or perimeter changes.
- Integration cost, control risk, service incidents or reversal time exceeds the approved envelope.
- Key local managers, suppliers or customers leave at a rate that invalidates the acquisition thesis.
- Four quarterly reviews or 12 to 18 months pass without reliable attribution; require a fresh ownership and integration decision rather than extending the test by default.
Limitations and promotion gaps
- Candidate status reflects one qualified supporting case paired with a separately reconstructed failure; it is not corpus-validated.
- Priceline's public record does not disclose the exact internal gates, integration budget, decision rights or counterfactual path.
- The observed international perimeter changes across Booking.com Limited, Bookings B.V., Agoda and rentalcars.com, so this case does not identify a standalone acquisition return or causal percentage.
- Staging can delay genuine scale benefits, duplicate systems and complicate controls; thresholds must be calibrated before closing rather than copied from this case.
- The rule is a governance candidate, not a recommendation to buy, hold or sell the acquirer's securities.
rule.gate-acquisition-integration-on-causal-synergy-evidence
Preserve the target's standalone core; before closing, have accountable owners approve target-health non-inferiority bands and acquirer net-contribution gates; release each irreversible integration wave only after independent review finds the lower confidence bound on attributable net contribution above zero for two consecutive quarters, target health inside its band and integration spending inside the approved envelope; if the thesis remains unverified after four quarterly reviews or 12 to 18 months, re-underwrite ownership and integration rather than extend the test by default.
Target growth can coexist with absent acquirer synergies; frozen baselines, test-and-control evidence and staged release gates distinguish standalone momentum from incremental integration economics while preserving the option to stop.
Use when
- An acquisition thesis depends materially on incremental contribution to the acquirer's existing businesses rather than only growth in the target's standalone business.
- Earnouts or management scorecards emphasize target-side users, revenue, gross profit or similar measures that can improve without proving the claimed acquirer-side contribution.
- A protected standalone structure, commercial pilot or modular integration release can test the thesis before deeper integration becomes difficult to reverse.
Do not transfer when
- Contractually committed and independently verified acquirer-side economics already exceed the downside case after all integration costs and dis-synergies.
- Delay would destroy a separately evidenced opportunity whose expected value exceeds the staged alternative under an approved downside analysis.
Reverse or kill if
- Incremental acquirer-side contribution remains below the approved gate for two consecutive quarterly reviews after perimeter and attribution checks.
- Target health deteriorates outside its approved band or causal measurement cannot separate standalone momentum from integration effects.
- Integration cash spending, organizational complexity or service risk exceeds the precommitted envelope.
- A commercial agreement, minority position or separation preserves the target's standalone value with better downside protection.
- Four consecutive quarterly reviews, or 12 to 18 months after closing, pass without verifying the causal contribution thesis; require a fresh ownership and integration re-underwriting rather than an automatic extension.
Limitations and promotion gaps
- Candidate status reflects one reconstructed case and does not establish cross-case validity.
- The public record does not reveal eBay's complete internal integration scorecard, experiment design, integration spending or board deliberations.
- Some platform and network synergies emerge slowly or resist clean experiments, so thresholds and review periods require transaction-specific calibration.
- Staging preserves reversibility but can sacrifice speed, coordination benefits or bargaining leverage; the rule does not prove the staged counterfactual would have produced a higher return.
- A false positive can delay a real opportunity, duplicate platforms, fragment control or weaken accountability; independent review is a decision gate, not proof that delay is costless.
rule.stage-repurchases-behind-reinvestment-and-refinancing-gates
Release incremental cash repurchases only after period-matched reinvestment, operating-cash-flow, funded-debt, fixed-charge, covenant, refinancing, valuation, and net-share gates pass; reconcile existing contracts and add no new repurchase derivative while a material obligation or funding source is unresolved.
Staged gates preserve operating and refinancing optionality, prevent authorization or gross purchases from being mistaken for owner-value creation, and make discretionary capital return reversible before it crowds out higher-priority uses.
Use when
- Discretionary repurchases compete with store, distribution, technology, inventory, people, or working-capital reinvestment.
- Cash treasury purchases are material relative to period-matched operating cash flow and reported capex.
- Debt, lease, fixed-charge, covenant, refinancing, open-contract, or valuation inputs are incomplete or capable of changing the decision.
Do not transfer when
- All required reinvestment is independently approved and funded, every material obligation is reconciled, stressed liquidity and refinancing remain inside approved buffers, and a capitalization-complete valuation supports the contemplated purchase price.
- Delay would destroy a separately evidenced opportunity whose expected cost exceeds the information value and optionality preserved by staging.
Reverse or kill if
- Pause new discretionary purchases and derivatives when required reinvestment is impaired, deferred, or cannot be measured on the approved basis.
- Reverse capital return toward liquidity or debt reduction when stressed refinancing, covenant, fixed-charge, or maturity conditions breach their approved buffers.
- Withdraw any owner-value or buyback-alpha claim when capitalization, purchase-price, issuance, option, contract, or counterfactual inputs are incomplete.
- Reopen the rule if stable-scope cross-case evidence shows ungated acceleration consistently dominates staging after reinvestment, financing risk, price, and alternative uses are controlled.
Limitations and promotion gaps
- AutoZone is one selected-endpoint success case; it does not reveal the actual board gates, treasury policy, transaction-level valuation, or rejected alternatives.
- FY2003 to FY2024 contains an approximately 21-year evidentiary gap, so the case does not establish uninterrupted discipline.
- Bed Bath & Beyond is a directional boundary failure, not a matched capital-return experiment; horizons, fiscal periods, liquidity conditions, business models, and accounting perimeters differ.
- Positive operating-cash-flow-minus-capex residuals and lower net shares do not prove that repurchases were self-funded, low risk, or value-accretive.
- Threshold calibration must be issuer-, contract-, industry-, and cycle-specific and requires human approval for material accounting or publication judgments.
rule.bbby.gate-discretionary-capital-return-on-cash-resilience
Suspend discretionary repurchase tranches and require a fresh human capital-release approval only after cash-generation, borrowing-base, vendor-continuity, and valuation gates clear.
Deferral preserves an exercisable liquidity option for inventory, vendors, leases, debt service, and operating repair while additional evidence is gathered; it also avoids treating authorization or a plan as already-spent cash.
Use when
- A proposed repurchase acceleration makes a previously deferrable capital schedule near-term and irreversible.
- Period-matched reported operating cash flow after total capex is nonpositive or deteriorating under the same disclosed definition.
- Borrowing capacity depends materially on collateral, reserves, covenants, or letters of credit, or material vendor terms and shipment continuity are unresolved.
- A point-in-time fully diluted valuation and downside operating cash forecast are incomplete.
Do not transfer when
- Verified excess liquidity remains above a human-approved downside buffer after the tranche under current collateral and covenant conditions.
- Vendor terms, shipment commitments, inventory availability, and operating cash generation are stable under predeclared thresholds.
- Reproducible point-in-time valuation and fully diluted capitalization establish a sufficient margin of safety after considering alternative uses of cash.
Reverse or kill if
- Cancel or defer the tranche after one material vendor prepayment or shipment-continuity breach that lacks an approved substitute.
- Cancel or defer if verified post-tranche liquidity falls below the human-approved downside buffer.
- Re-underwrite after two consecutive nonpositive residual-cash reviews or any material deterioration in borrowing-base collateral.
- Require new human approval after a material financing, dilution, covenant, lease, or restructuring event.
Limitations and promotion gaps
- This is a candidate from one failure episode; the ex-ante recommendation matching the realized direction of stress does not validate or promote the rule.
- The two-consecutive-review threshold, downside-liquidity buffer, and review cadences are uncalibrated governance proposals that require owner and human calibration; they are not empirical safety levels and this episode does not validate them.
- The paired AutoZone record spans materially different reporting periods and roughly twenty-four years, while this outcome window is about eighteen months; direct performance comparison would be invalid.
- AutoZone is intentionally not listed as a counterexample because the paired record does not establish the same conjunction of weakening residual cash, conditional borrowing capacity, unresolved vendor continuity, and incomplete valuation; the empty counterexample set keeps this candidate structurally unpromoted and does not assert that no counterexample exists.
- Bed Bath & Beyond first-half measures are not directly comparable to AutoZone fiscal or quarterly measures.
- The static retained-USD-400-million bridge does not estimate solvency, avoided bankruptcy, recovery, or operating response.
- Public evidence does not quantify the causal contribution of repurchases relative to merchandising, inventory, vendor, debt, lease, financing, and execution mechanisms.
rule.biopharma.require-regimen-level-clinical-gates-before-capitalizing-asset
Maintain only bounded exposure and release additional underwriting confidence after prespecified regimen-level efficacy, safety, regulatory, manufacturing and access gates clear; preserve abstention when a decision-critical gate remains unknown.
A molecule-level signal can fail to generalize across regimens, populations, doses, safety horizons or manufacturing execution, while explicit gates make the thesis falsifiable and keep later evidence from being smuggled into the original decision.
Use when
- A material acquisition or exposure decision depends on an unapproved biopharma asset whose evidence is earlier than the clinically and commercially decisive regimen-level endpoint.
- The available signal comes from a limited cohort, surrogate, non-randomized study or selected population and does not establish the full intended regimen, population and safety profile.
- Pivotal, regulatory and commercial gates can be defined before treating the asset as validated.
Do not transfer when
- The asset is already approved for the exact regimen and population being underwritten and the decision does not rely on unvalidated expansion.
- Downside exposure is immaterial, fully reversible and independently capped under an approved mandate.
Reverse or kill if
- A pivotal result fails the prespecified efficacy or safety gate or becomes uninterpretable for the intended regimen.
- Regulatory action rejects, delays or materially narrows the asset beyond the underwritten use.
- Financing, manufacturing, access or competition moves expected downside beyond the approved bound.
- Management substitutes an early cohort, surrogate, market forecast or strategic narrative for regimen-level evidence.
- Required capitalization, cash-flow, material-conflict or citation inputs are absent.
Limitations and promotion gaps
- Candidate status reflects one success episode paired with one failure episode; broader cross-case testing is required before promotion.
- The public record does not recover Gilead's internal diligence, governance or exact pre-signing clinical gates.
- Pairing does not establish that Gilead used these proposed gates, that BMS omitted them, or that applying them would have prevented or detected the later BMS outcome.
- FDA approval validates the labeled combination use, not monotherapy and not every future population or regimen.
- The rule governs evidence and exposure staging; it does not estimate acquisition value or a target price.
rule.biopharma.separate-asset-validation-from-acquisition-return
Classify clinical approval, commercial conversion, acquisition return, business quality and price attractiveness as separate conclusions; recognize bounded asset validation while abstaining from IRR or target-price claims until a deterministic audited cash-flow bridge is available.
Revenue is not acquisition cash flow, consolidated margins do not allocate product economics, and combination or execution effects prevent gross sales from proving the acquired asset's standalone return.
Use when
- An acquired biopharma asset later reaches approval, patient use or material product sales.
- The available record does not provide a complete product- and compound-level bridge from gross sales to timed acquisition cash flows.
- Combination products, sponsor execution, unmet need, payer behavior or competition can share causal and economic attribution.
Do not transfer when
- Audited product- and compound-level deductions, costs, incremental investment, taxes, working capital, financing and terminal cash flows are complete and reconciled.
- A separately approved methodology and human accounting review authorize the return calculation.
Reverse or kill if
- The approval is withdrawn or the marketed use no longer supports the bounded asset-validation conclusion.
- Product sales are restated or shown not to include the acquired asset.
- A claimed acquisition return relies on revenue divided by purchase price, reported price multiplied by patient use, or consolidated margins assigned to a product.
- Material accounting adjustments or ethical conclusions lack the required human approvals.
- Source lineage or bitemporal availability cannot be verified.
Limitations and promotion gaps
- Candidate status reflects one bounded success and one paired failure; the rule is not corpus validated.
- Pairing does not establish that Gilead used this separation rule, that BMS omitted it, or that applying it would have prevented or detected the later BMS outcome.
- The Gilead episode does not supply product-specific net cash flows, so it demonstrates the abstention boundary rather than acquisition IRR.
- Harvoni combines ledipasvir and sofosbuvir, and the selected record does not allocate compound-level economics.
- Price and access reporting supplies context but no human-approved ethics adjudication.
rule.biopharma.stage-consideration-before-long-duration-safety
Before signing, compare full acquisition with license, milestone, contingent-value, escrow, and tranche structures; document counterparty feasibility and option cost; have independent scientific reviewers predeclare longer-duration safety, efficacy, and regulatory gates; and require human approval before consideration or incremental capital passes each irreversible gate. If a signed agreement already fixes consideration, preserve the distinction and apply the gates only to still-reversible clinical, integration, and capital releases.
Staged consideration aligns cash irreversibility with information arrival, limiting failure-state exposure when an early signal does not survive longer-duration validation while preserving the option to invest after the evidence clears.
Use when
- An unapproved single or lead asset accounts for a material share of an acquisition's stated thesis or risk-adjusted value.
- Public or verified diligence evidence is concentrated in short exposure, early-stage efficacy, or small cohorts while longer-duration safety, pivotal efficacy, or regulatory validation remains unresolved.
- Most consideration would become irreversible before the next decision-critical clinical or regulatory evidence gate.
Do not transfer when
- Representative longer-duration safety and pivotal evidence already clear predeclared independent thresholds before consideration becomes irreversible.
- Verified counterparty refusal or delay cost makes staging infeasible and an independently reproduced, source-complete expected-value analysis shows that the full-commitment alternative remains superior under the approved failure state.
- Legal, ethical, or patient-protection obligations require immediate action; no financial staging rule may delay a necessary safety stop.
Reverse or kill if
- Immediately stop dosing or escalation and follow the independent safety and regulatory process after a sentinel signal or material clinical hold; patient protection overrides transaction economics.
- Do not release the next financial or development tranche when a predeclared safety, efficacy, quality, or regulatory gate fails or cannot be verified.
- Re-underwrite or terminate the staged path when irreversible failure-state exposure exceeds the approved budget or counterparty terms eliminate meaningful reversibility.
- Require a fresh human decision if delay cost, competitive loss, or new representative evidence invalidates the original staging comparison.
Limitations and promotion gaps
- Candidate status reflects one failure episode paired with one successful acquisition outcome; the pair is not a tested process-rule counterexample and cannot estimate a universal optimal upfront percentage, gate duration, or technical-success probability.
- The public record does not establish that Inhibitex would have accepted a staged structure or quantify price, delay, control, tax, exclusivity, or competitive costs.
- Rare or compound-specific toxicity may remain unpredictable despite strong diligence and longer observation, so staging controls financial exposure rather than guaranteeing safety or success.
- A successful fully funded acquisition can be rational ex ante, and a failed staged program can still destroy value; realized outcome alone does not score decision quality.
- The rule does not authorize an investor or public adviser to rewrite a signed agreement and does not substitute for clinician, regulator, board, legal, ethics, or accounting judgment.
rule.valuation.separate-affordability-from-attractiveness
Evaluate financing capacity and investment attractiveness in separate decision records; bind every valuation input to its source and knowledge time; independently reproduce the buyer-specific expected-value and failure-state bridges; and abstain from intrinsic-value approval, IRR, or target price until decision-critical gaps are resolved. Capacity may pass a financing gate but must never substitute for value evidence.
Liquidity reduces financing and distress risk but does not validate scientific probability, synergy cash flows, price, or expected return; separating the tests prevents an affordable commitment from being mislabeled attractive.
Use when
- A buyer's reported liquidity or financing capacity is offered as support for a material acquisition or development commitment.
- Consideration exceeds a relevant disclosed reference range or depends materially on buyer-specific synergies, technical-success probabilities, launch timing, or terminal value.
- A source-complete buyer cash-flow, capitalization, tax, financing, and failure-state bridge is unavailable or not independently reproducible.
Do not transfer when
- Independently verified contractual cash flows and downside protection make the value case insensitive to the disputed scientific, synergy, or terminal assumptions.
- A qualified human decision-maker explicitly accepts an unquantified strategic objective and records that no intrinsic-value, IRR, or target-price conclusion is being made.
Reverse or kill if
- Withdraw the attractiveness conclusion when the buyer value bridge loses decision-critical lineage, cannot be reproduced, or relies on liquidity as a valuation input.
- Re-underwrite when a scientific, regulatory, synergy, launch, financing, or recovery assumption moves outside its predeclared range.
- Escalate for human approval when failure-state exposure exceeds the approved downside case even if financing capacity remains adequate.
- Preserve valuation abstention when capitalization, cash-flow, or material-conflict inputs remain missing; never fabricate a target price.
Limitations and promotion gaps
- Seller-adviser ranges may be incomplete or conservative and do not substitute for buyer-specific valuation; an observed gap is a diligence trigger, not proof of overpayment.
- Financial capacity can have genuine strategic option value and reduce financing risk, but those benefits still require separate valuation and downside lineage.
- The BMS public record lacks a complete buyer model and acquisition-return bridge, so this case cannot establish ex-ante overpayment or a realized total loss.
- The paired Gilead-Pharmasset outcome shows that a large, fully funded acquisition can achieve bounded asset validation; it does not validate conflating affordability with attractiveness and is not a tested counterexample to this process rule.
- Candidate status requires further cross-case testing, explicit counterexamples, and transaction-specific thresholds before promotion.
rule.require-obligation-adjusted-funded-liquidity-before-cyclical-capacity-release
Recommend that the documented human capital-allocation committee release no incremental discretionary capacity or acquisition capital until a reconciled obligation-adjusted funded-liquidity schedule passes the approved downside case; keep total capex, acquisition cash use, assumed liabilities, working capital, and integration costs separate, and stage the next release behind price, margin, utilization, startup, and facility-level cash milestones. The rule authorizes no autonomous capital action.
A gross liquidity balance can overstate capacity when cyclical working-capital needs and transaction obligations arrive together. Staging preserves the option to stop a reversible capital use before it converts market stress into a funding problem, while still allowing supported low-cycle investment after essential obligations are covered.
Use when
- A cyclical issuer is considering material capacity, startup, or acquisition spending while realized prices, margins, volumes, or working capital are under stress.
- Reported cash, current ratios, or nominal facilities appear adequate, but committed capex, acquisition consideration, assumed liabilities, integration costs, covenants, or other fixed obligations are incomplete.
- The investment can be staged, deferred, resized, or made contingent on facility-level milestones without breaching an existing obligation.
Do not transfer when
- Delay is contractually impossible and a separately approved analysis shows the expected cost of delay exceeds the information and liquidity option value preserved by staging.
- Every material obligation is reconciled, downside funding is committed and covenant compliant, essential maintenance and working capital are funded, and facility-level economics pass approved hurdles.
Reverse or kill if
- Pause discretionary capacity and acquisition releases when obligation-adjusted downside liquidity or covenant buffers fail.
- Resize, defer, or exit a project when facility-level price, margin, startup, utilization, or cash milestones fail without funded remediation.
- Reopen the rule if stable-scope cross-case evidence shows that ungated low-cycle capacity consistently dominates staging after obligations, transaction terms, and opportunity costs are controlled.
Limitations and promotion gaps
- Nucor is one selected-endpoint success case; public sources do not reveal the actual internal gates, rejected uses, project hurdles, or obligation-adjusted liquidity schedule.
- The Bethlehem Steel pair is a directional boundary case, not a matched experiment; product mix, production technology, labor and retirement obligations, asset age, capital structure, and restructuring paths differ.
- Positive OCF-minus-total-capex residuals, reported facilities, and later profitability do not prove adequate funded liquidity, optimal timing, or attractive project returns.
- Transaction feasibility and numeric buffer calibration are issuer-, contract-, facility-, and cycle-specific and require human approval.
rule.separate-resilience-from-price-and-acquisition-return
Keep operational resilience, underwriting readiness, business quality, price attractiveness, shareholder return, and acquisition return as separate conclusions; attribute issuer statements, disclose rival mechanisms, and abstain from target price, intrinsic value, TSR attribution, acquisition IRR, or adequate-return claims until each required evidence set and human approval is complete.
Survival and consolidated cash generation answer whether an issuer endured the cycle, not whether its shares were attractively priced or each acquisition earned its opportunity cost. Separate evidence gates prevent favorable endpoints from laundering missing capitalization, transaction, and counterfactual inputs into investment-return claims.
Use when
- A later operating recovery or balance-sheet improvement is being used to support a claim about equity price attractiveness, shareholder return, or acquisition success.
- Consolidated results embed cycle, price, volume, working-capital, acquisition, integration, policy, and accounting-perimeter changes.
- Point-in-time market capitalization, transaction-level invested capital, subsequent capex, facility cash flows, opportunity costs, or a controlled counterfactual are missing.
Do not transfer when
- A point-in-time capitalization and approved valuation independently support the price conclusion without relying on hindsight outcome selection.
- Acquisition-level invested capital, assumed obligations, subsequent capex, working capital, facility cash flows, hurdle rates, and a defensible counterfactual support the transaction-return conclusion.
Reverse or kill if
- Withdraw a price or shareholder-return conclusion when point-in-time capitalization, market, forecast, or portfolio inputs become incomplete.
- Withdraw an acquisition-return conclusion when transaction-level invested capital, obligations, cash flows, hurdle rates, or counterfactuals cannot be reconciled.
- Reopen the rule only if stable cross-case evidence shows that selected operating endpoints reliably identify price or transaction returns without the separated inputs.
Limitations and promotion gaps
- The rule is a candidate derived from one selected case and the repository's evidence-governance requirements, not a validated empirical predictor.
- Consolidated filings may not disclose acquisition-level cash flows or internal opportunity costs, so abstention can remain necessary even after operations improve.
- A successful acquisition can coexist with poor equity entry price, and an attractive equity entry can coexist with a weak acquisition; the rule does not infer either direction.
- Material accounting adjustments, ethics conclusions, valuation, and publication still require the designated human approvals.
rule.bethlehem.executed-liquidity-fixed-obligation-gate
Recommend that the human underwriting committee reduce exposure to a pre-approved minimum or abstain, and require documented human re-underwriting and approval before restoration after executed financing, usable-liquidity, operating-cash and fixed-obligation gates clear under a downside case.
A common downturn becomes equity-threatening when operating cash burn and fixed claims consume the issuer's time to realize capacity, mix, cost or price improvements; proposed liquidity does not settle near-term cash uses.
Use when
- A cyclical issuer is using operating cash while disclosed liquidity and covenant headroom are deteriorating.
- Survival depends on proposed rather than executed credit, asset-sale or covenant-waiver capacity.
- Pension, retiree-health, labor or other fixed obligations lack a date-specific downside cash schedule.
Do not transfer when
- Legally executed facilities, bank-confirmed borrowing availability and covenant headroom cover the approved downside schedule.
- Verified plant and product cash margins plus unrestricted cash generation clear precommitted restoration thresholds.
Reverse or kill if
- Reverse the reduction only after executed credit and downside liquidity headroom are independently verified and remain above committee floors.
- Kill the rule if a broader paired-case corpus shows proposed financing and accounting fixed-obligation balances reliably predict usable liquidity without document and cash-schedule verification.
Limitations and promotion gaps
- This single episode does not establish universal dollar, ratio or quarter-count thresholds.
- Product mix, technology, asset age, customer geography, labor and benefit structures, raw-material positions, trade policy, acquisition history, the 2002 tariff and later steel-price cycle limit transferability, including to Nucor.
rule.bethlehem.asset-continuity-versus-equity-survival
Underwrite operational asset continuity, debtor legal-entity survival, old common-equity survival and each claimant-class recovery as separate outcomes before assigning success or failure.
Assets and production can continue under debtor-in-possession protection or a new owner while the old parent's plan liquidates, old shares are canceled and creditor or pension claims absorb different losses.
Use when
- A distressed issuer continues operating in Chapter 11 or transfers operating assets to a buyer.
- Creditors, employees, pension participants and old common equity have different legal claims and recoveries.
Do not transfer when
- An authoritative restructuring record proves the same legal entity, security and claimant hierarchy continue unaltered.
Reverse or kill if
- Reverse an interim failure label if the same old security receives a positive recovery under an authoritative final record.
- Kill the rule if cross-case validation shows operational continuation reliably implies old legal-entity and common-equity survival without claimant-level analysis.
Limitations and promotion gaps
- The filed September 2003 plan treatment is not a later final distribution ledger.
- Bankruptcy law, plan structure, pension insurance and security seniority vary across jurisdictions and cases.
rule.odfl.require-independent-service-economics
Withhold service-dependent value and capital release until matched service, customer, pricing, claims-severity, and contribution evidence passes a human-approved independent gate.
High headline on-time performance can coexist with definition changes, exclusions, mix shifts, weak retention, adverse claim severity, or no economic monetization.
Use when
- A thesis credits superior service with retention, pricing, freight selection, or lower claims cost.
- Available service measures are issuer-reported, short-horizon, or lack stable definitions, denominators, severity, and independent controls.
Do not transfer when
- Independently reconciled shipment events, claims, customer cohorts, and realized pricing already cover the declared period on stable definitions.
- The decision does not depend on a service advantage and remains acceptable under a no-advantage case.
Reverse or kill if
- Remove service-advantage credit after a definition break or the precommitted human-approved breach rule is met.
- Re-underwrite immediately if claim severity, retention, or realized contribution deteriorates despite a favorable headline on-time rate.
Limitations and promotion gaps
- No numeric withholding range, validation-window length, or breach count is calibrated from this single case.
- Public evidence does not reveal ODFL's exact service definitions, control procedures, customer cohorts, or economic thresholds.
rule.odfl.require-terminal-economics-before-density-credit
Treat aggregate shipments per location as a descriptive coordinate only; stage exposure or capital until terminal and lane utilization, required maintenance, and cash contribution clear downside gates.
Aggregate growth can hide underused sites, adverse lanes, excess handling, empty miles, rising maintenance, or cross-subsidies and therefore cannot establish marginal density economics.
Use when
- A capital-intensive network thesis relies on density, spare capacity, or greater ownership of physical locations.
- Evidence consists mainly of aggregate shipment and year-end location counts rather than terminal- and lane-level economics.
Do not transfer when
- Verified terminal- and lane-level contribution after required maintenance already supports the thesis across approved downside cases.
- The contemplated action remains acceptable after assigning zero value to unverified density leverage.
Reverse or kill if
- Stop a density-dependent tranche when selected terminals or lanes fail the approved contribution or liquidity buffer.
- Re-underwrite after an acquisition, network redesign, definition change, or material divergence between aggregate growth and terminal economics.
Limitations and promotion gaps
- No staging fraction or capital-deferral range is calibrated from this single case.
- Shipments divided by year-end centers mixes a duration numerator with an endpoint denominator and cannot identify the within-year network path.
rule.odfl.separate-business-outcome-from-security-return
Score the business outcome and the investment-decision outcome separately; abstain from TSR, recommendation-error, target-price, price-attractiveness, and sizing conclusions until the security and portfolio record is complete.
A strong business can be a poor investment at one price and an excellent investment at another, while a no-add process can be appropriate even when the business later succeeds.
Use when
- A later business outcome is used to judge an earlier public-equity recommendation.
- The earlier security price, capitalization, actual portfolio action, distributions and corporate actions, mandate, exposure, or risk budget is missing.
Do not transfer when
- A point-in-time price and capitalization, actual portfolio action, complete split-and-distribution-adjusted return path, mandate, exposure, and risk budget are reconciled and independently approved.
Reverse or kill if
- Withdraw any return or recommendation-error conclusion if a price, corporate action, portfolio action, or mandate input fails verification.
- Recompute under a governed deterministic return bridge after any restatement of the security record.
Limitations and promotion gaps
- No return or effect range is supplied; the rule governs evidence sufficiency, not the direction or magnitude of any eventual security return.
- A complete return calculation still would not by itself prove that the original process was good or bad without comparing the evidence available ex ante.
rule.yrc.service-density-proof-before-integration-credit
Do not credit the integration as a durable advantage in underwriting; require a human committee to maintain, reduce or restore exposure only after governed stable-cohort service and cash-contribution gates clear.
Network density creates value only when consolidation increases route and terminal contribution without losing service-sensitive freight or adding rehandling; footprint and shipment aggregates cannot identify that mechanism by themselves.
Use when
- A network operator claims that terminal, technology or linehaul integration will increase density or lower handling cost.
- Public evidence lacks stable lane, terminal, route and customer cohorts tying service, handlings, density and cash contribution together.
- Aggregate volume or operating performance is weakening while the transformation remains incomplete or disputed.
Do not transfer when
- Governed shipment-event, claims, handling and contribution ledgers show sustained service-consistent density on stable definitions.
- Independent customer-retention and terminal-level cash evidence reconciles to the filed operating and cash-flow statements.
Reverse or kill if
- Reverse a no-credit decision only after stable-cohort service and contribution evidence clears precommitted human-approved gates.
- Kill or materially revise the candidate rule if paired cases show aggregate integration metrics reliably predict service-consistent cash contribution without cohort evidence.
Limitations and promotion gaps
- One failure episode cannot set universal service levels, quarter counts or density thresholds.
- Geography, shipment mix, terminal architecture, labor structure, technology, fuel and purchased-transportation exposure limit transferability, including to Old Dominion.
rule.yrc.conditional-liquidity-fixed-obligation-gate
Recommend no initiation or add and escalate any existing exposure to a human committee; restore only after unrestricted cash, executable availability, covenants and every dated fixed obligation clear an approved downside cash schedule.
Thin conditional liquidity shortens the time available for service and operating recovery, and fixed claims can become binding even when gross cash, accounting profit or nominal facility capacity appears adequate.
Use when
- Operating cash flow does not cover identified gross reinvestment on the stated narrow perimeter.
- Reported cash or facility availability depends on reserves, eligibility, waivers or later restricted-cash transfers.
- Debt, leases, pensions, labor payments or other fixed obligations lack a reconciled downside payment schedule.
Do not transfer when
- Bank-confirmed unrestricted cash and drawable availability cover all reserves, conditions, maturities and committed uses under the approved downside case.
- A reconciled cash-flow and fixed-obligation schedule remains above human-approved buffers without unexecuted financing or asset-sale assumptions.
Reverse or kill if
- Reverse only after executed financing and downside liquidity headroom are independently verified and every material fixed-use schedule is reconciled.
- Kill or revise the candidate rule if a broader paired-case corpus shows nominal cash and availability reliably substitute for the full executable-liquidity and fixed-use bridge.
Limitations and promotion gaps
- Operating cash flow less gross capital expenditures is not free cash flow and does not include every source or use.
- The USD 102.2 million report-date coordinate is a mixed-time issuer measure, not matched unrestricted liquidity.
rule.yrc.business-legal-security-perimeters
Classify operating-business outcome, asset continuity, debtor legal-entity status, old-security recovery and investor return separately; abstain from final recovery and return claims until authoritative class-level distributions and an observed trade record exist.
Operating assets and legal entities can continue under debtor-in-possession protection even after the customer-facing network stops, while old equity and creditor classes have distinct and unresolved recovery paths.
Use when
- A company's ordinary operations cease or enter wind-down while one or more legal entities continue in court-supervised restructuring.
- Public securities continue trading or their recoveries remain subject to a plan and creditor hierarchy.
Do not transfer when
- An authoritative record shows the same ordinary operations, legal entity and security perimeter continue without restructuring or claimant-class change.
Reverse or kill if
- Reverse an interim security-outcome label only when an authoritative later record establishes final treatment or distribution.
- Kill or revise the candidate rule if cross-case validation shows operating cessation reliably determines legal-entity and security outcomes without claimant-level analysis.
Limitations and promotion gaps
- This case stops at August 14, 2023 and does not establish final old-equity recovery, creditor distributions or asset disposition.
- Bankruptcy law, entity structure, collateral and security priority vary by jurisdiction and case.
rule.stage-semiconductor-roadmaps-behind-independent-and-customer-proof
Defer any agent-proposed exposure increase and route the case to authorized human underwriting; release capital only through precommitted technical, customer-production, stable-scope economic, manufacturing-funding, and valuation gates, with customer announcements treated as one signal rather than complete proof.
A launch can establish availability and a customer announcement can establish a configuration or intended use, but neither alone proves repeat production demand, contribution economics, manufacturing resilience, or an attractive security price.
Use when
- A semiconductor thesis depends materially on a new CPU GPU accelerator or process roadmap converting into customer production use and durable economics.
- Issuer launch claims or customer announcements are available but reproducible workload economics qualification volume retention or product contribution remains incomplete.
- Funding manufacturing or valuation gates could make premature exposure costly even if the product later succeeds.
Do not transfer when
- Independent technical evidence, verified customer production and repeat demand, stable-scope economics, manufacturing capacity, and downside funding all clear precommitted thresholds.
- A separate authorized human valuation and portfolio-risk package supports the proposed action at the then-current price.
Reverse or kill if
- Reverse a defer decision only after all evidence gates and a separate human-approved valuation and portfolio package clear.
- Kill or narrow the rule if a controlled cross-case corpus shows launch and customer-announcement evidence alone reliably predicts production economics and investment outcomes without the specified gates.
Limitations and promotion gaps
- The selected AMD record contains customer-authored adoption signals but no complete product-level volume retention contribution-margin or controlled workload series.
- This single episode cannot establish universal quarter counts benchmark thresholds or valuation requirements.
rule.bridge-acquisition-and-reporting-perimeters-before-causal-attribution
Require a deterministic pre-close, acquired, retained, discontinued, and consolidated bridge before causal or organic-growth language; preserve original and recast presentation vintages, and abstain from sole attribution when stable-scope product economics remain unavailable.
Acquisitions, divestitures, discontinued operations, segment aggregation, and issued shares can change both the numerator and denominator, so a mathematically correct endpoint comparison can still be non-organic and causally ambiguous.
Use when
- A reported growth or margin comparison spans acquisitions divestitures discontinued operations segment reorganizations or material share issuance.
- The endpoint includes products or operations absent from the starting period.
- The proposed conclusion attributes consolidated or segment change to one roadmap product or management action.
Do not transfer when
- Audited stable-scope schedules reconcile acquired and organic revenue profit cash flow assets and shares to the consolidated presentation.
- The conclusion is explicitly limited to a single source-reported perimeter and makes no organic-growth or sole-cause inference.
Reverse or kill if
- Reverse attribution abstention only after a stable-scope deterministic bridge and human accounting review reconcile every material perimeter.
- Kill or narrow the rule if controlled cross-case evidence shows acquisition-expanded endpoint comparisons reliably isolate organic product causality without transaction and reporting bridges.
Limitations and promotion gaps
- Public filings may not disclose product-level acquired contribution or the internal management ledger needed for a complete organic bridge.
- The rule controls scope and attribution but does not determine whether an acquisition created value or whether the security was attractively priced.
rule.separate-regulatory-charges-and-conditional-dilution-gates
Track gross charge, reversal, and net period effect as separate issuer-attributed records; track issued, vested, exercisable, exercised, outstanding, and maximum conditional shares separately; run downside funding and per-share stress tests under authorized human review without treating reversals as certainty or conditional maxima as realized dilution.
Regulatory decisions can impair inventory and market access before recoveries are known, while milestone warrants can create economic exposure without being vested or outstanding; premature netting hides path dependence and overstates certainty.
Use when
- Export licensing or another regulatory restriction creates an inventory or related charge with later reversals or recoveries.
- A customer or strategic agreement includes a warrant or other equity instrument whose vesting or exercise depends on future milestones.
- An analysis could net the charge or count the conditional shares without preserving gross events and unmet conditions.
Do not transfer when
- The regulatory exposure is immaterial under an approved downside case and all gross charges recoveries and cash effects reconcile on one period and product perimeter.
- The equity instrument has expired or every condition and share-state transition is independently reconciled to the capitalization ledger.
Reverse or kill if
- Reverse regulatory or dilution abstention only after gross-to-net charge and equity-state waterfalls reconcile and an authorized human approves the downside and valuation effects.
- Kill or narrow the rule if a controlled cross-case corpus shows net reported charges and maximum conditional shares alone preserve path risk and realized per-share economics without separate state ledgers.
Limitations and promotion gaps
- The selected filing states approximate charge amounts and endpoint warrant conditions but does not provide a complete license-by-customer reserve or probability schedule.
- The rule does not assign probabilities to future regulatory approvals customer milestones or warrant exercise and therefore cannot produce a target price.
rule.require-semiconductor-roadmap-evidence-chain
Defer new capital and route the case to an authorized human underwriting committee; require a versioned planned-versus-actual evidence chain across technical validation, product timing, qualification, customer deployment, segment economics, and funding before any human-approved change in exposure.
A named node, launch, or high-volume label can show activity without proving competitive yield, reliable qualification, customer adoption, or adequate economics, while process misses can propagate into product timing and fixed-cost absorption.
Use when
- A semiconductor thesis depends materially on a process-node or product-launch cadence.
- Issuer roadmaps and milestone labels are not joined to independently verified yield reliability qualification volume customer-deployment and economic records.
- A missed schedule or changed architecture can interact with high fixed cost and customer adoption before consolidated financial results reveal the full effect.
Do not transfer when
- Independent engineering, customer-qualification, production-volume, and financial evidence clears all precommitted gates on stable definitions.
- An authorized human committee documents why a temporary miss does not impair the approved downside case and separately approves valuation and portfolio risk.
Reverse or kill if
- Reverse a defer decision only after the complete evidence chain and a separate human-approved valuation and portfolio package clear their gates.
- Kill or materially narrow the rule if a broader controlled corpus shows issuer milestone labels reliably predict qualification volume and economics without the specified evidence chain.
Limitations and promotion gaps
- The 2015 10nm, 2020 7nm, and 2025 18A and 14A labels are different technologies and are not treated as one directly comparable metric series.
- This single episode does not establish universal yield thresholds, delay lengths, quarter counts, or exposure actions.
rule.separate-products-foundry-and-intersegment-economics
Require the human underwriting committee to underwrite product economics, manufacturing economics, external foundry economics, intersegment pricing and eliminations as separate ledgers; abstain from an all-company quality or failure conclusion until the bridges are reconciled.
Internal transfer revenue can demonstrate production activity without external customer validation, and profitable products can coexist with manufacturing losses that consolidated results or a single segment narrative obscures.
Use when
- An integrated semiconductor company reports product and manufacturing or foundry segments that contain intersegment activity.
- External revenue, transfer prices, consolidation eliminations, segment reorganizations, or midyear divestitures can change the meaning of reported segment totals.
- One segment is profitable while another reports large losses or requires external volume for economic efficiency.
Do not transfer when
- Audited stable-scope segment and consolidation schedules establish that intersegment pricing eliminations and external economics are immaterial to the decision.
- The decision thesis explicitly concerns only one bounded segment and portfolio risk has been approved on that same perimeter.
Reverse or kill if
- Reverse abstention only after stable product foundry external and consolidation bridges clear human review.
- Kill the rule if cross-case validation shows intersegment-heavy segment totals can be used as external demand and company-wide return measures without transfer-price or elimination analysis.
Limitations and promotion gaps
- Public segment reporting may not expose product-level transfer prices, customer contribution, or the management ledger used internally.
- The rule distinguishes perimeters but does not prescribe an integrated-device-manufacturer or fabless architecture as universally superior.
rule.reconcile-semiconductor-capital-and-funding-perimeters
Require an authorized human committee to approve one obligation-adjusted sources-and-uses schedule that preserves every GAAP, supplemental, ownership, incentive, vendor-financing, partner, equity and non-GAAP perimeter; abstain from capital-return, valuation, and exposure changes until the schedule and downside funding gates clear.
Cash classification, payment timing, noncash acquisition, shared ownership, incentives, dilution and asset sales can make gross investment, net investment, reported cash generation and shareholder funding appear interchangeable when they are not.
Use when
- A capital-intensive semiconductor issuer reports cash PP&E investing outflows, financing-activity PP&E payments, noncash PP&E, incentives, partner contributions, equity-linked proceeds, or divestiture proceeds on different perimeters.
- Management also reports adjusted net capex or free-cash-flow measures that net selected sources or uses.
- Reported cash PP&E additions can exceed operating cash generation on the archive's descriptive period check while maintenance and required-investment scope remain unresolved.
Do not transfer when
- A complete audited schedule reconciles cash, noncash, financing, partner, government, equity, divestiture, ownership and obligation effects on stable definitions.
- A human-approved downside case shows usable liquidity, covenant headroom, committed capital, customer volume and expected returns remain inside precommitted bounds.
Reverse or kill if
- Reverse abstention only after the obligation-adjusted schedule and a separate human-approved valuation and portfolio package are complete.
- Kill or narrow the rule if a multi-case validation corpus demonstrates that the excluded capital and funding perimeters are consistently immaterial to solvency dilution and return conclusions.
Limitations and promotion gaps
- The selected public record does not contain project-level cash flows, hurdle rates, customer commitments, covenant calculations, or partner distributions needed to estimate manufacturing returns.
- OCF minus cash PP&E additions is only a scale check and does not measure free cash flow, a funding gap, maintenance capital, or distributable cash.
rule.transdigm.separate-moat-customer-outcomes
Underwrite product necessity, switching, price-cost-value, customer alternatives, quality, legal compliance, audit findings and remediation as separate gates; abstain from a customer-value or ethics conclusion when any decision-critical gate lacks evidence.
The same source position can reflect genuine differentiated value, bargaining power, contested pricing or a mixture, so margin and recurrence cannot identify customer outcomes by themselves.
Use when
- A company attributes durable economics to proprietary, sole-source, regulated or difficult-to-substitute products.
- Customers include governments, safety-critical operators or other stakeholders whose alternatives and bargaining power may be constrained.
Do not transfer when
- Independently verified product-level evidence shows immaterial customer concentration, abundant qualified alternatives and no material pricing or safety asymmetry.
Reverse or kill if
- Stop favorable customer-value or ethics claims when material contract-level evidence is missing or contradicted.
- Route any material unresolved legal, pricing, safety, quality or customer-harm conflict to authorized human review before external action or publication.
Limitations and promotion gaps
- One case and two government samples cannot estimate a general rate of customer harm or rule effectiveness.
- A benchmark-defined excess-profit finding is not automatically illegality, a universal profit ceiling or a portfolio-wide result.
rule.transdigm.gate-serial-acquirer-capital
Keep acquisition cohorts, organic operations, required reinvestment, distributions and financing in separate deterministic bridges; condition further irreversible capital on predeclared cohort-return, cash, maturity, covenant and customer-outcome gates.
Consolidated operating strength can coexist with purchased growth, refinancing dependence and cash distributions, while aggregate results conceal which cohorts earned fully loaded returns and which funding obligations remain fragile.
Use when
- A serial acquirer combines material acquisition spending with debt financing, refinancing or shareholder distributions.
- Consolidated growth and margins are available but stable acquisition-cohort cash returns and stressed funding headroom are not.
Do not transfer when
- The transaction and distribution are demonstrably immaterial to liquidity, leverage, management capacity and customer continuity under approved thresholds.
Reverse or kill if
- Stop or reprice the commitment if the cohort return cannot clear the approved downside hurdle on fully loaded cash flows.
- Defer distributions and acquisitions when the stressed funding path is incomplete or breaches an approved buffer.
- Re-underwrite after two consecutive material cohort, integration or funding-path misses.
Limitations and promotion gaps
- The public TransDigm record does not supply cohort IRRs or a complete covenant model, so the rule is process-oriented and uncalibrated.
- Debt and distributions are not inherently value-destructive; company-specific opportunity cost, taxes, financing terms and valuation matter.
rule.serial-acquirer.require-decision-unit-economics-before-crediting-organic-growth
Keep the agent read-only, refuse to credit the growth label as verified decision-unit economics, and route the evidence gap and any proposed exposure change to the human investment committee; route patient-access or pricing concerns to the human ethics reviewer.
Acquisition mix, price changes, inventory timing, rebates, and accounting allocations can make portfolio-level growth look durable while the underlying product and channel cash economics are weaker or differently attributed.
Use when
- An issuer reports organic, pro forma organic, or existing-business growth while acquisitions materially change the portfolio.
- Product-level net price, units, mix, channel inventory, returns, patient access, retention, and required reinvestment do not reconcile to consolidated GAAP revenue and cash flow.
- Management asks the underwriting process to credit durability, short payback, or acquisition IRR before a stable decision-unit ledger exists.
Do not transfer when
- A human-approved reconciliation binds product and channel net revenue, contribution, reinvestment, working capital, and cash realization to consolidated filings on stable definitions.
- The amount is immaterial to the decision under an explicit and human-approved materiality threshold.
Reverse or kill if
- Withdraw any credited organic-growth conclusion when a later filing restates revenue or reveals material channel, control, allocation, or definition defects.
- Restore abstention when acquisition cohorts or products cannot be traced through cash realization and required reinvestment.
- Escalate immediately when pricing or access evidence creates material patient or ethics concerns; the agent must not adjudicate them.
Limitations and promotion gaps
- This single case does not establish a universal reconciliation threshold or prove that acquisition-led growth is inherently low quality.
- Public filings may not disclose the smallest decision-unit ledger; the rule therefore often produces abstention rather than a definitive conclusion.
- Pricing, access, and patient impact require human ethical and domain review, not automated classification.
rule.serial-acquirer.tie-acquisition-returns-to-accounting-controls-and-downside-liquidity
Require independent accounting-control and downside-liquidity gates before crediting acquisition returns; keep every exposure, accounting adjustment, ethics conclusion, and external action human-approved, and otherwise maintain abstention or bounded exposure.
Leverage reduces tolerance for integration, pricing, product, and accounting errors, while weak control lineage can delay recognition that expected acquisition returns are not converting into governed GAAP earnings and cash.
Use when
- A serial acquirer forecasts synergies, adjusted earnings accretion, short payback, or acquisition IRR while goodwill, intangibles, leverage, and integration demands are material.
- Executed financing, downside covenant headroom, accounting-control ownership, and post-close cash-return measurement are incomplete or rely on commitment capacity rather than funded terms.
- A material acquisition can be staged, rejected, or reflected through a bounded public-equity exposure decision.
Do not transfer when
- Executed financing and downside liquidity remain ample after severe human-approved stress cases, and covenant calculations are independently reproduced.
- A human-approved acquisition-cohort ledger reconciles consideration, financing, synergies, integration costs, product reinvestment, taxes, working capital, impairments, divestitures, and realized cash returns.
Reverse or kill if
- Suspend acquisition-return credit when a restatement, material weakness, unexplained allocation, covenant shortfall, or unreconciled cohort variance appears.
- Reverse an exposure recommendation only through the designated human investment authority after the corrected evidence and downside case are reviewed.
- Kill the rule for a decision when transaction control is impossible and speed has demonstrably greater value than staged information, but record that human-approved exception explicitly.
Limitations and promotion gaps
- The case supports the need for linked controls, not a universal leverage ceiling, covenant buffer, or acquisition hurdle rate.
- Reported impairment is not equivalent to acquisition cash loss, and later debt decline is not proof of operating deleveraging on a constant perimeter.
- A conservative gate can reject value-creating acquisitions when public or internal information is incomplete; humans must weigh that option cost.
rule.acquisition.separate-business-scale-from-acquisition-return
Classify closing, business continuity, scale, standalone economics, acquisition return, business quality and price attractiveness separately; recognize only the dimensions supported by evidence and abstain from IRR, target price, position size or shareholder-return attribution until a deterministic audited bridge is available.
Revenue and registrations are not cash flow, purchase accounting is not realized return, and consolidated issuer performance cannot identify the acquired business's incremental contribution without a counterfactual and timed allocation.
Use when
- An acquired business later reports substantial revenue, users, customers or other operating scale.
- The selected record lacks a complete standalone and incremental bridge from reported scale to timed acquisition cash flows.
- Purchase accounting, integration costs, counterfactual results, capitalization or security-price inputs remain incomplete.
Do not transfer when
- Audited standalone and incremental cash flows, integration costs, taxes, working capital, financing and terminal cash flows are complete and timed.
- Point-in-time capitalization, security prices, forecasts, discount rates and counterfactuals are available under an approved methodology.
Reverse or kill if
- Reported scale is restated, misdefined or shown not to belong to the acquired business.
- A purported return relies on revenue divided by purchase price or on registrations described as engagement.
- Presentation changes are treated as economic deterioration or silently overwrite original facts.
- Material accounting adjustments lack human approval or evidence lineage fails verification.
Limitations and promotion gaps
- Candidate status reflects one bounded success and one paired failure; the rule is not corpus validated.
- The Microsoft episode does not supply acquisition IRR, so it demonstrates separation and abstention rather than return measurement.
- Pairing does not prove either issuer used this rule or that applying it would have changed either outcome.
rule.acquisition.gate-integration-under-announced-autonomy
Keep the issuer on a research watchlist, authorize no exposure action, and require authorized human re-underwriting only after non-substitutable closing, funding, autonomy, talent, customer, product, accounting, privacy, cash-economics and valuation gates have auditable evidence.
Announced autonomy may limit disruption but is not proof of execution; separate gates prevent reported scale or strategic narrative from substituting for cash economics, controls, customer outcomes or price discipline.
Use when
- A signed acquisition announces retained brand, culture, leadership or operating independence while also promising strategic product or distribution benefits.
- A public-equity underwriter cannot control the issuer's integration actions and lacks complete valuation and risk-budget inputs.
- Closing, financing, talent, customer, product, controls, privacy and cash-economics risks can be observed through separate gates.
Do not transfer when
- The requested task is research-only and cannot affect exposure, publication or external action.
- Complete decision-time evidence and an authorized human process already support a different action under an approved mandate.
Reverse or kill if
- Management substitutes the announced autonomy narrative or user scale for evidence of execution and cash economics.
- Material customer, talent, control, privacy, remedy or financing deterioration breaches a prespecified gate.
- The learner is asked to maintain, initiate, add, reduce or exit without current exposure, mandate, valuation and risk-budget evidence.
- Source availability is backdated or later outcome evidence is inserted into the frozen decision state.
Limitations and promotion gaps
- The public record does not reveal Microsoft's confidential integration process, so the rule is a teaching prescription rather than a claim about what Microsoft did.
- Announced autonomy may be neither necessary nor sufficient for success and can coexist with selective integration.
- HP–Autonomy is a paired counterexample for research, not proof that the rule would have prevented its outcome.
- The rule is not corpus validated; candidate status requires broader cross-case testing before promotion.
rule.acquisition-underwrite-accounting-quality-and-integration-bandwidth
Separate public-equity exposure from acquisition-governance advice. Abstain from target price, position size, add, retain, reduce, or exit conclusions until complete valuation, capitalization, cash-flow, and conflict inputs are source-linked and human approved. For monitoring, request public or authoritatively supplied evidence of a ring-fenced target ledger, accountable operating core, contract quality, revenue, receivables, deferred revenue, and cash. Treat issuer-side integration waves as underwritten only after customer health, incremental cash contribution, control readiness, liquidity, and leadership-capacity benchmarks pass for two consecutive quarterly reviews. If evidence remains unavailable or material benchmarks fail through four quarterly reviews, continue exposure abstention and require fresh human-owned public-equity underwriting. Any operational pause or release remains an issuer decision.
High prices amplify errors in reported economics and synergy forecasts, while simultaneous transformation can slow decisions and remediation. Stable ledgers, independent accounting tests, explicit accountable owners, reversible integration waves, and precommitted cash gates prevent strategic narrative, adjusted metrics, and impairment hindsight from replacing evidence.
Use when
- A transformative acquisition is priced on reported growth, adjusted margins, strategic fit, or cross-sell synergies that are material to the acquirer's public-equity thesis.
- Target reporting granularity, transaction-level accounting, cash conversion, or adjusted-to-GAAP or IFRS reconciliation remains decision-critical and incomplete.
- The acquirer is simultaneously executing portfolio, product, restructuring, financing, or leadership changes that can compete for accountable management capacity.
Do not transfer when
- Immediate integration is required by law, safety, cybersecurity, financial-control remediation, or a separately evidenced existential operating risk.
- Contractually committed and independently verified net cash synergies exceed the staged alternative after full integration costs, dis-synergies, customer risk, and downside cases.
Reverse or kill if
- Material transaction, revenue-recognition, receivable, deferred-revenue, or cash exceptions remain unresolved after two independent reviews.
- Customer health or target cash conversion remains below the approved downside gate for two consecutive quarters after data-quality checks.
- Incremental net cash contribution remains below the approved gate or cannot be separated from standalone momentum, market effects, or perimeter changes.
- Integration cost, service incidents, control risk, or reversal time exceeds the precommitted envelope.
- Critical accountable owners depart or management decision latency invalidates the approved execution sequence.
- Four quarterly reviews pass without reliable accounting, contribution, and attribution evidence; require a fresh ownership and integration decision.
Limitations and promotion gaps
- Candidate status reflects one reconstructed failure paired with a separately reconstructed acquisition success; it is not corpus-validated.
- Public evidence does not reveal HP's complete private diligence, actual integration gates, approved budgets, or decision logs.
- The contemporaneous bandwidth warning is third-party evidence and does not establish realized management failure or causal effect.
- Bounded legal findings do not validate HP's original causal dollar attribution or make different parties and proceedings interchangeable.
- The SEC's at-least-USD-45-million fixes finding and the court's USD 45 million auditor-settlement credit are unrelated values and must never be netted or equated.
- The rule governs evidence and monitoring; it is not a recommendation to buy, hold, sell, or size the acquirer's securities.
rule.pixar.preserve-distinct-creative-identity
Treat identity, leadership, talent, decision rights, release cadence and franchise extension as separate post-close gates; keep the issuer on a research watchlist and require authorized human re-underwriting before any exposure action when a material gate is unresolved.
Selective organizational separation may protect the routines that generate creative output while allowing distribution and franchise options, but announced autonomy is not proof of execution and output scale is not financial return.
Use when
- A signed acquisition depends materially on a target's creative process, brand identity, key talent and release quality rather than only on separable assets.
- The acquirer announces retained operations, locations, leadership or decision rights while also seeking distribution and franchise benefits.
- The public-equity underwriter cannot direct integration and must judge it from externally observable evidence.
Do not transfer when
- The target's value is demonstrably independent of people, identity, decision rights and creative routines.
- Complete current evidence and an authorized human process support a different action under an approved mandate.
Reverse or kill if
- Authoritative evidence shows retained identity or autonomy materially impaired controls, customer outcomes or economics.
- The named creative identity continues but output quality, cadence or franchise relevance deteriorates across multiple cycles.
- Management substitutes brand continuity or box-office gross for standalone cash economics and acquisition return.
- A broader case set shows operating separation is neither necessary nor useful under comparable creative-acquisition conditions.
Limitations and promotion gaps
- Candidate status reflects one bounded success and one designated counterexample; it is not corpus-validated.
- The public record does not reveal complete integration decision rights, talent cohorts or internal creative controls.
- Continued identity and output do not prove that autonomy caused the outcome or that the purchase earned an adequate return.
- The rule and Daimler–Chrysler pairing do not prove causality or prevention and do not establish that applying the rule would have changed either outcome.
rule.pixar.separate-deal-price-from-return
Version every price coordinate by date and basis, reconcile only like-for-like accounting values, classify business continuity separately, and abstain from acquisition IRR, TSR or alpha, target price and position size until a deterministic audited return and valuation bridge is complete.
Transaction value, purchase accounting, box office, segment results and proprietary title ROI answer different questions; combining them silently can manufacture a return conclusion that the evidence does not support.
Use when
- An acquisition record contains announced transaction value, stated net value, later rounded purchase price, final GAAP purchase price, purchase accounting or title-level scale measures.
- The selected record lacks complete timed standalone and incremental cash flows, integration costs, counterfactual performance and terminal value.
- Consolidated segment, multi-title or proprietary title metrics cannot be attributed exclusively to the acquisition cohort.
Do not transfer when
- Audited standalone and incremental cash flows, integration and reinvestment costs, taxes, financing, counterfactuals and terminal cash flows are complete and timed.
- Current market price, diluted capitalization, forecasts, discount rate, mandate, exposure and risk budget are available under an approved methodology.
Reverse or kill if
- A return calculation uses box-office gross, consolidated segment income or proprietary title ROI as if it were Pixar acquisition cash flow.
- Issued shares and converted awards are added as though they were the same equity unit.
- A subcomponent included in another purchase-allocation line is counted again as an additive asset.
- Material accounting adjustments lack human approval or source-to-output lineage fails verification.
Limitations and promotion gaps
- The episode demonstrates disciplined separation and abstention, not a measured acquisition return.
- The selected filings do not provide a complete standalone Pixar cash-flow series or acquisition counterfactual.
- The rule is not corpus-validated and requires testing across more successes, failures and mixed outcomes before promotion.
- The rule and Daimler–Chrysler pairing do not prove causality or prevention and do not establish that applying the rule would have changed either outcome.
rule.pixar.require-non-substitutable-acquisition-gates
Maintain non-substitutable gates for closing, creative identity and talent, operating autonomy and controls, output and customer relevance, accounting and cash economics, and capitalization and valuation; pass each gate independently and refer any exposure or publication decision to an authorized human.
Closing does not prove integration, output does not prove cash return, purchase accounting does not prove value creation, and business quality does not establish price attractiveness.
Use when
- A transformative acquisition has material closing, dilution, identity, talent, operating-control, output, accounting, cash-economics and valuation uncertainty.
- Favorable evidence in one dimension could tempt an analyst to waive missing evidence in another.
- The learner is an external public-equity underwriter with no issuer-operating or trading authority.
Do not transfer when
- The work is research-only and cannot affect exposure, publication or another external action.
- A complete approved underwriting package already satisfies every material gate with current, point-in-time evidence.
Reverse or kill if
- A gate is passed using evidence from a different economic perimeter or a later knowledge date than the decision boundary.
- A favorable creative result is used to waive missing capitalization, cash flow, conflict or citation evidence.
- Material evidence contradicts the announced identity, control or output model and is not re-underwritten.
- Broader cross-case testing shows the gate set is not predictive, is redundant or systematically delays better decisions without reducing error.
Limitations and promotion gaps
- The rule describes an external analyst process and is not a claim about Disney's confidential integration controls.
- Gates reduce category errors but do not guarantee a successful acquisition or investment outcome.
- The rule is not corpus-validated; candidate status and one counterexample are insufficient for promotion.
- The rule and Daimler–Chrysler pairing do not prove causality or prevention and do not establish that applying the rule would have changed either outcome.
rule.daimlerchrysler.integration-decision-rights-before-synergy
Keep closing, economic ownership, operating decision rights, leadership retention, customer and product continuity, implementation costs, and realized cash benefits as non-substitutable gates; maintain research-only abstention and require authorized human re-underwriting when a material gate is unresolved.
A signed governance structure and synergy forecast can coexist with unclear authority, execution friction, competitive pressure, and costly restructuring; passing one gate does not supply evidence for another.
Use when
- A transformative merger depends on cross-border or cross-organizational integration, shared leadership, cultural compatibility, and material forecast benefits.
- Announced governance representation differs from economic ownership or does not specify durable operating decision rights.
- Benefit forecasts lack independently tested baselines, implementation-cost schedules, attribution controls, or cash-realization evidence.
Do not transfer when
- The transaction does not depend materially on organizational integration or shared operating decisions.
- Complete current evidence and an authorized human process support a different action under an approved mandate.
Reverse or kill if
- Announced governance or culture statements are substituted for observed operating authority and execution.
- Revenue or gross cost savings are used to waive a material operating-profit, cash-flow, workforce, plant, or customer deterioration.
- Later evidence is backfilled into an earlier point-in-time decision packet.
- Broader cross-case testing shows the gate set is redundant, non-predictive, or systematically harmful under comparable conditions.
Limitations and promotion gaps
- Candidate status reflects one bounded failure paired with one bounded-success counterexample; it is not corpus-validated.
- The public record does not reveal complete internal decision rights, leadership deliberations, integration budgets, or realized synergy ledgers.
- Observed deterioration and separation do not prove that unclear decision rights caused the outcome or that the rule would have prevented it.
- The Disney–Pixar counterexample does not establish a universal autonomy or governance prescription.
rule.daimlerchrysler.separate-transfer-cash-objects
Version each transaction object by date and basis, reconcile only the exact reported cash bridge, preserve funded, undrawn, contingent, accounting, and ownership exposures separately, and abstain from proceeds, return, or value-destruction totals until an authoritative common-perimeter bridge is complete.
Contribution, withdrawal, receivable repayment, deconsolidated cash, investing inflow, accounting loss, retained equity, credit, and guarantees answer different economic questions; silent substitution or addition double counts flows and misstates risk.
Use when
- A divestiture, deconsolidation, recapitalization, or control transfer contains capital contributions, seller withdrawals, debt or intercompany repayments, deconsolidated cash, accounting gains or losses, retained equity, funded loans, undrawn commitments, or guarantees.
- The reported values use different currencies, dates, cash-flow classifications, accounting scopes, realization states, or probability bases.
- A headline sale-price, proceeds, or value-destruction conclusion could be manufactured by silently netting unlike objects.
Do not transfer when
- An audited reconciliation explicitly converts every object to the same date, currency, scope, realization state, and probability basis.
- A named output intentionally uses only one source-defined coordinate and discloses its limitations.
Reverse or kill if
- Intercompany repayment is relabeled as purchase consideration without authoritative support.
- Accounting losses are added to overlapping discontinued-operation losses or treated as cash outflow without reconciliation.
- Funded, undrawn, contingent, and equity exposures are summed across currencies at face value.
- A material accounting adjustment or fair-value conversion lacks human approval and source-to-output lineage.
Limitations and promotion gaps
- The rule prevents category errors but does not itself measure sale economics, merger return, or total value destroyed.
- The selected record does not provide a complete fair-value and realization schedule for every continuing guarantee.
- This candidate is not corpus-validated and requires testing across more control transfers, divestitures, and deconsolidations before promotion.
- The Disney–Pixar counterexample involves acquisition accounting rather than a comparable deconsolidation; the rule and pairing do not prove causality, prevention, or that applying the rule would have changed either outcome.
rule.daimlerchrysler.require-costed-cash-synergy-ledger
Record benefits as issuer forecasts, require a period-by-period gross-benefit, implementation-cost, restructuring, reinvestment, working-capital, tax, and financing ledger, and do not promote synergy, valuation, or exposure conclusions until realized net cash is independently reconciled.
Revenue scale and named benefit mechanisms can coexist with collapsing operating profit and costly restructuring; only a costed cash ledger distinguishes gross claims from incremental owner economics.
Use when
- Management announces material merger benefits, compatibility, or scale mechanisms before close.
- The record lacks a stable standalone baseline, implementation-cost budget, cash timing, attribution method, and downside triggers.
- Later revenue growth could obscure margin deterioration, restructuring, or cash absorption.
Do not transfer when
- The transaction thesis does not rely on integration benefits or cost savings.
- Audited standalone and incremental cash-flow evidence already provides a complete counterfactual benefit and cost bridge.
Reverse or kill if
- Gross savings or revenue scale are presented without implementation costs, cash timing, or counterfactual attribution.
- Plans and forecasts are relabeled as realized values.
- Consolidated or segment outcomes are attributed solely to the merger without controlling external shocks and business-specific factors.
- Complete cross-case evidence shows costed ledgers do not improve forecast calibration or decision quality.
Limitations and promotion gaps
- The selected DaimlerChrysler sources do not provide a complete realized synergy ledger, so the episode supports abstention and monitoring rather than a quantified shortfall.
- Competitive incentives and auto-cycle conditions are plausible rival explanations for part of the deterioration.
- This candidate is not corpus-validated; one supporting case and one paired counterexample are insufficient for promotion.
- The rule and Disney–Pixar pairing do not prove causality, prevention, or that applying the rule would have changed either outcome; applying it does not guarantee a successful transaction or investment return.